quan20210930

0001851734-21-000104.txt : 20211116 0001851734-21-000104.hdr.sgml : 20211116 20211116151956 ACCESSION NUMBER: 0001851734-21-000104 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 40 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211116 DATE AS OF CHANGE: 20211116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUANTRX BIOMEDICAL CORP CENTRAL INDEX KEY: 0000820608 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330202574 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-17119 FILM NUMBER: 211415761 BUSINESS ADDRESS: STREET 1: P.O. BOX 4960 CITY: TUALATIN STATE: OR ZIP: 97062 BUSINESS PHONE: 267-880-1595 MAIL ADDRESS: STREET 1: P.O. BOX 4960 CITY: TUALATIN STATE: OR ZIP: 97062 FORMER COMPANY: FORMER CONFORMED NAME: AFEM MEDICAL CORP DATE OF NAME CHANGE: 19970722 FORMER COMPANY: FORMER CONFORMED NAME: XTRAMEDICS INC /NV/ DATE OF NAME CHANGE: 19920703 10-Q 1 quan20210930_10q.htm FORM 10-Q quan20210930_10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File No. 000-17119

QUANTRX BIOMEDICAL CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

Nevada		33-0202574
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification Number)

10190 SW 90th Avenue, Tualatin, Oregon 97062

(Address of Principal Executive Offices) (Zip Code)

(212) 980-2235

(Registrant's Telephone Number, Including Area Code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☐ No ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-Accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Exchange Act: Common Stock, par value $0.01 per share

The number of shares outstanding of the issuer’s common stock as of November 15, 2021 was 78,696,461.

TABLE OF CONTENTS

		PAGE
PART I - FINANCIAL INFORMATION

ITEM 1.	Financial Statements	1

	Balance Sheets as of September 30, 2021 (Unaudited) and December 31, 2020	1

	Statements of Operations (Unaudited) for the three and nine months ended September 30, 2021 and 2020	2

	Statements of Cash Flows (Unaudited) for the nine months ended September 30, 2021 and 2020	3

	Quarterly Statements of Stockholders Equity (Unaudited) for the three and nine months ended September 30, 2021 and 2020	4

	Condensed Notes to (Unaudited) Financial Statements	5

ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	10

ITEM 4.	Controls and Procedures	13

PART II - OTHER INFORMATION

ITEM 1.	Legal Proceedings	14

ITEM 1A.	Risk Factors	14

ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	14

ITEM 3.	Defaults Upon Senior Securities	14

ITEM 4.	Mine Safety Disclosures	14

ITEM 5.	Other Information	14

ITEM 6.	Exhibits	14

Signatures		15

-i-

PART I – FINANCIAL INFORMATION

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

THIS QUARTERLY REPORT ON FORM 10-Q, INCLUDING EXHIBITS HERETO, CONTAIN FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF SECTION 27A OF THE SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. THESE FORWARD-LOOKING STATEMENTS ARE TYPICALLY IDENTIFIED BY THE WORDS “ANTICIPATES,” “BELIEVES,” “EXPECTS,” “INTENDS,” “FORECASTS,” “PLANS,” “ESTIMATES,” “MAY,” “FUTURE,” “STRATEGY,” OR WORDS OF SIMILAR MEANING. VARIOUS FACTORS COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE EXPRESSED IN THE FORWARD-LOOKING STATEMENTS, INCLUDING THOSE DESCRIBED IN “RISK FACTORS” IN OUR ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2020. WE ASSUME NO OBLIGATIONS TO UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT NEW INFORMATION, ACTUAL RESULTS, CHANGES IN ASSUMPTIONS, OR CHANGES IN OTHER FACTORS, EXCEPT AS REQUIRED BY LAW.

-ii-

ITEM 1. Financial Statements

QUANTRX BIOMEDICAL CORPORATION

BALANCE SHEETS

	September 30,			December 31,
	2021			2020
	(Unaudited)			(Audited)
ASSETS
Current Assets:
Cash and cash equivalents	$	21,051		$	55,428
Total Current Assets		21,051			55,428

Investments, net of impairment of $500,000		-			-
Total Assets	$	21,051		$	55,428

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current Liabilities:
Accounts payable	$	18,754		$	16,312
Notes Payable		1,387,694			1,387,694
Accrued interest on notes payable		1,017,012			866,226
Notes Payable, related party and accrued interest		177,649			166,251
Total Liabilities		2,601,109			2,436,483

Commitments and Contingencies		-			-

Stockholders’ Equity (Deficit):
Preferred stock; $0.01 par value, 25,000,000 authorized shares; 20,500,000 shares designated as Series B Convertible Preferred Stock; Series B Convertible Preferred shares 6,196,893 issued and outstanding		61,969			61,969
Common stock; $0.01 par value; 150,000,000 authorized; 78,696,461 shares issued and outstanding		786,964			786,964
Stock to be issued		8,600			8,600
Additional paid-in capital		48,876,398			48,876,398
Accumulated deficit		(52,313,989	)		(52,114,986	)
Total Stockholders’ Equity (Deficit)		(2,580,058	)		(2,381,055	)

Total Liabilities and Stockholders’ Equity (Deficit)	$	21,051		$	55,428

The accompanying condensed notes are an integral part of these financial statements.

-1-

QUANTRX BIOMEDICAL CORPORATION

STATEMENTS OF OPERATIONS

(unaudited)

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2021			2020			2021			2020
Costs and Operating Expense:
Sales, general and administrative	$	2,810		$	1,908		$	9,457		$	8,797
Professional fees		5,732			8,784			27,363			32,235
Professional fees, related party		-			-			-			10,500
Total Costs and Operating Expenses		8,542			10,692			36,820			51,532

LOSS FROM OPERATIONS:		(8,542	)		(10,692	)		(36,820	)		(51,532	)

Other Income (Expense):
Interest Expense		(54,473	)		(54,474	)		(162,183	)		(162,247	)
Gain (loss) on forgiveness of accounts payable		-			-			-			24,610
Total Other Income (Expense), net		(54,473	)		(54,474	)		(162,183	)		(137,637	)

Profit (Loss) Before Taxes		(63,015	)		(65,166	)		(199,003	)		(189,169	)

Provision for Income Taxes		-			-			-			-

Net Profit (Loss)	$	(63,015	)	$	(65,166	)	$	(199,003	)	$	(189,169	)

Basic and Diluted Net Loss per Common Share	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

Basic and Diluted Weighted Average Shares Used in per Share Calculation		78,696,461			78,696,461			78,696,461			78,696,461

The accompanying condensed notes are an integral part of these interim financial statements.

-2-

QUANTRX BIOMEDICAL CORPORATION

STATEMENTS OF CASH FLOWS

(unaudited)

	For the Nine Months Ended
	September 30,
	2021			2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(199,003	)	$	(189,169	)
Adjustments to reconcile net loss to net cash used by operating activities:
Loss (gain) on forgiveness of accounts payable		-			(24,610	)
(Increase) Decrease in:
Prepaid expense		-			7,000
Increase (Decrease) in:
Accounts Payable		2,442			(24,553	)
Accrued interest		162,184			162,247
Net Cash Used by Operating Activities		(34,377	)		(69,085	)

CASH FLOWS FROM INVESTING ACTIVITIES
Net Cash Provided by Investing Activities		-			-

CASH FLOWS FROM FINANCING ACTIVITIES
Net Cash Provided (Used) by Financing Activities		-			-

Net Increase (Decrease) in Cash and Cash Equivalents		(34,377	)		(69,085	)

Cash and Cash Equivalents, Beginning of Period		55,428			130,351

Cash and Cash Equivalents, End of Period	$	21,051		$	61,266

Supplemental Cash Flow Disclosures:
Interest expense paid in cash	$	-		$	-
Income tax paid	$	-		$	-

The accompanying condensed notes are an integral part of these interim financial statements.

-3-

QUANTRX BIOMEDICAL CORPORATION

STATEMENTS OF STOCKHOLDERS’ EQUITY

(unaudited)

	Preferred Stock				Common Stock
	Number of Shares		Amount		Number of Shares		Amount		Additional Paid-in Capital		Stock to be Issued		Accumulated Deficit			Total
*For the three months ended September 30, 2020*
BALANCE, July 1, 2020		6,196,893	$	61,969		78,696,461	$	786,964	$	48,876,398	$	8,600		(51,986,255	)		(2,172,993	)
Net loss for the three months ended September 30, 2020														(65,166	)		(65,166	)
BALANCE, September 30, 2020		6,196,893	$	61,969		78,696,461	$	786,964	$	48,876,398	$	8,600	$	(52,051,421	)	$	(2,317,490	)

*For the nine months ended September 30, 2020*
BALANCE, January 1, 2020		6,196,893	$	61,969		78,696,461	$	786,964	$	48,876,398	$	8,600		(51,862,252	)		(2,128,321	)
Net loss for the nine months ended September 30, 2020		-		-		-		-		-		-		(189,169	)		(189,169	)
BALANCE, September 30, 2020		6,196,893	$	61,969		78,696,461	$	786,964	$	48,876,398	$	8,600	$	(52,051,421	)	$	(2,317,490	)

*For the three months ended September 30, 2021*
BALANCE, July 1, 2021		6,196,893	$	61,969		78,696,461	$	786,964	$	48,876,398	$	8,600		(52,250,974	)		(2,517,043	)
Net loss for the three months ended September 30, 2021														(63,015	)		(63,015	)
BALANCE, September 30, 2021		6,196,893	$	61,969		78,696,461	$	786,964	$	48,876,398	$	8,600	$	(52,313,989	)	$	(2,580,058	)

*For the nine months ended September 30, 2021*
BALANCE, January 1, 2021		6,196,893	$	61,969		78,696,461	$	786,964	$	48,876,398	$	8,600		(52,114,986	)		(2,381,055	)
Net loss for the nine months ended September 30, 2021		-		-		-		-		-		-		(199,003	)		(199,003	)
BALANCE, September 30, 2021		6,196,893	$	61,969		78,696,461	$	786,964	$	48,876,398	$	8,600	$	(52,313,989	)	$	(2,580,058	)

The accompanying condensed notes are an integral part of these interim financial statements.

-4-

QUANTRX BIOMEDICAL CORPORATION

CONDENSED NOTES TO FINANCIAL STATEMENTS

(unaudited)

1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

Overview

As used in this Quarterly Report on Form 10-Q, the terms “Company”, “we”, “our”, “us”, “QuantRx” or the “Company” refers to QuantRx Biomedical Corporation, unless context otherwise requires. QuantRx Biomedical Corporation was incorporated on December 5, 1986, in the State of Nevada. Our principal business office is located at 10190 SW 90th Avenue, Tualatin, Oregon 97062.

We have developed and intend to commercialize our patented miniform pads (“PADs”) and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses and other medical needs. We are also developing and intend to commercialize genomic diagnostics for the laboratory market, based on our lateral flow patents. Our platforms include: inSync®, UniqueTM, and OEM branded over-the-counter and laboratory testing products based on our core intellectual property related to our PAD technology.

The continuation of our operations remains contingent upon the receipt of additional financing required to execute our business and operating plan, which is currently focused on the commercialization of our PAD technology either directly or through a joint venture or other relationship intended to increase shareholder value. In the interim, we have nominal operations, focused principally on maintaining our intellectual property portfolio and maintaining compliance with the public company reporting requirements. In order to continue as a going concern, we will need to raise capital, which may include through the issuance of debt and/or equity securities. No assurances can be given that we will be able to obtain additional financing under terms favorable to us, if at all, or otherwise successfully develop a business and operating plan or enter into an alternative relationship to commercialize our PAD technology.

Our principal business line consists of over-the-counter commercialization of our InSync feminine hygienic interlabial pad, the Unique® Miniform for hemorrhoid application, and other treated miniforms (the “OTC Business”), as well as maintaining established and continuing licensing relationships related to these products. We also own certain diagnostic testing technology (the “Diagnostic Business”, and collectively with the OTC Business, the "Business") that is based on our lateral flow patents. Management believes this corporate structure permits us to more efficiently explore options to maximize the value of our products and intellectual property portfolio, with the objective of maximizing the value of the Businesses for the benefit of the Company and our shareholders.

Our current focus is to obtain additional working capital necessary to continue as a going concern, and to develop a longer term financing and operating plan to: (i) commercialize our over-the-counter products either directly or through joint ventures, mergers or similar transactions intended to capitalize on potential commercial opportunities; (ii) contract manufacturing of our over-the-counter products to third parties while maintaining control over the manufacturing process; (iii) maintain our intellectual property portfolio with respect to patents and licenses pertaining to both the OTC Business and the Diagnostics Business; and (iv) maximize the value of our investments in non-core assets. As a result of our current financial condition, however, our efforts in the short-term will be focused on obtaining financing necessary to maintain the Company as a going concern.

We follow the accounting guidance outlined in the Financial Accounting Standards Board Codification guidelines. The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted principles for interim financial information and with the items under Regulation S-X required by the instructions to Form 10-Q. They may not include all information and footnotes required by United States Generally Accepted Accounting Principles (“GAAP”) for complete financial statements. However, except as disclosed herein, there have been no material changes in the information disclosed in the notes to the financial statements for the year ended December 31, 2020 included in the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on April 15, 2021. The interim unaudited financial statements presented herein should be read in conjunction with those financial statements included in the Form 10-K. In the opinion of Management, all adjustments considered necessary for a fair presentation, which unless otherwise disclosed herein, consisting primarily of normal recurring adjustments, have been made. Operating results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021.

Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on previously reported losses, total assets or stockholders’ equity.

-5-

2. MANAGEMENT STATEMENT REGARDING GOING CONCERN

We currently are not generating revenue from operations, and do not anticipate generating meaningful revenue from operations or otherwise in the short-term. We have historically financed our operations primarily through issuances of equity and the proceeds from the issuance of promissory notes. In the past, we also provided for our cash needs by issuing Common Stock, options and warrants for certain operating costs, including consulting and professional fees, as well as divesting its minority equity interests and equity-linked investments. In addition, in the fiscal year ended 2018, we received cash payments as consideration for the sale and transfer of the Purchased Assets to Preprogen.

Our history of operating losses, limited cash resources and the absence of an operating plan necessary to capitalize on our assets raise substantial doubt about our ability to continue as a going concern absent a strengthening of our cash position. Management is currently pursuing various funding options, including seeking debt or equity financing, licensing opportunities and the sale of certain investment holdings, as well as a strategic, merger or other transaction to obtain additional funding to continue the development of, and to successfully commercialize, our products. There can be no assurance that the Company will be successful in its efforts. Should we be unable to obtain adequate financing or generate sufficient revenue in the future, the Company’s business, result of operations, liquidity and financial condition would be materially and adversely harmed, and we will be unable to continue as a going concern.

There can be no assurance that, assuming we are able to strengthen its cash position, we will achieve sufficient revenue or profitable operations to continue as a going concern.

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to GAAP and have been consistently applied in the preparation of the financial statements.

Accounting for Share-Based Payments. The Company follows the provisions of ASC Topic 718, which establishes the accounting for transactions in which an entity exchanges equity securities for services and requires companies to expense the estimated fair value of these awards over the requisite service period. The Company uses the Black-Scholes option pricing model in determining fair value. Accordingly, compensation cost has been recognized using the fair value method and expected term accrual requirements as prescribed. During the three and nine months ended September 30, 2021 and 2020, the Company had no stock compensation expense.

In the case of modifications, the Black-Scholes model is used to value modified warrants on the modification date by applying the revised assumptions. The difference between the fair value of the warrants prior to the modification and after the modification determines the incremental value. In the past, the Company has modified warrants in connection with the issuance of certain notes and note extensions. These modified warrants were originally issued in connection with previous private placement investments. In the case of debt issuances, the warrants were accounted for as original issuance discount based on their relative fair values. When modified in connection with a note issuance, the Company recognizes the incremental value as a part of the debt discount calculation, using its relative fair value in accordance with ASC Topic 470-20, “Debt with Conversion and Other Options”. When modified in connection with note extensions, the Company recognized the incremental value as prepaid interest, which is expensed over the term of the extension.

The fair value of each share-based payment is estimated on the measurement date using the Black-Scholes model with the following assumptions, which are determined at the beginning of each year and utilized in all calculations for that year. During the three and nine months ended September 30, 2021 and 2020, the Company did not make any Black-Scholes model assumptions, as no share-based payments were made during those periods.

- 6-

Risk-Free Interest Rate. The interest rate used is based on the yield of a U.S. Treasury security as of the beginning of the year.

Expected Volatility. The Company calculates the expected volatility based on historical volatility of monthly stock prices over a three-year period.

Dividend Yield. The Company has never paid cash dividends, and does not currently intend to pay cash dividends, and thus has assumed a 0% dividend yield.

Expected Term. For options, the Company has no history of employee exercise patterns. Therefore, the Company uses the option term as the expected term. For warrants, the Company uses the actual term of the warrant.

Pre-Vesting Forfeitures. Estimates of pre-vesting option forfeitures are based on Company experience. The Company will adjust its estimate of forfeitures over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from such estimates. Changes in estimated forfeitures will be recognized through a cumulative catch-up adjustment in the period of change and will also impact the amount of compensation expense to be recognized in future periods.

Earnings per Share. The Company computes net income (loss) per common share in accordance with ASC Topic 260. Net income (loss) per share is based upon the weighted average number of outstanding common shares and the dilutive effect of common share equivalents, such as options and warrants to purchase common stock, convertible preferred stock and convertible notes, if applicable, that are outstanding each year. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the “treasury stock” and/or “if converted” methods as applicable.

For the three and nine months ended September 30, 2021 and the three and nine months ended September 30, 2020, basic and diluted earnings per share were the same at the reporting dates of the accompanying financial statements, as including common stock equivalents in the calculation of diluted earnings per share would have been antidilutive.

As of September 30, 2021, the Company has no outstanding options, as all options expired in 2020. As of September 30, 2021, the Company had outstanding warrants exercisable for 15,000,000 shares of its common stock $0.01 par value (“Common Stock”), and outstanding preferred stock, $0.01 par value (“Preferred Stock”) convertible into 6,196,893 shares of its Common Stock, which options, warrants and Preferred Stock were deemed to be antidilutive for the nine months ended September 30, 2021. At September 30, 2021, the Company had reserved for issuance to certain investors 860,000 shares of its Series B Convertible Preferred Stock, convertible into 860,000 shares of its Common Stock. As of September 30, 2020, the Company has estimated and reserved for issuance approximately 20.0 million shares of Common Stock for a future conversion of its issued and outstanding Convertible Notes Payable.

As of September 30, 2020, the Company had no outstanding options. As of September 30, 2020, the Company had outstanding warrants exercisable for 15,000,000 shares of its Common Stock, and outstanding Preferred Stock convertible into 6,196,893 shares of its Common Stock, which options, warrants and Preferred Stock were deemed to be antidilutive for the nine months ended September 30, 2020. At September 30, 2020, the Company had reserved for issuance to certain investors 860,000 shares of its Series B Convertible Preferred Stock, convertible into 860,000 shares of its Common Stock. As of September 30, 2020, the Company has estimated and reserved for issuance approximately 20.0 million shares of Common Stock for a future conversion of its issued and outstanding Convertible Notes Payable.

Fair Value. The Company has adopted ASC Topic 820, “Fair Value Measurements and Disclosures” for both financial and nonfinancial assets and liabilities. The Company has not elected the fair value option for any of its assets or liabilities.

Use of Estimates. The accompanying financial statements are prepared in conformity with accounting principles generally accepted in the United States of America, and include certain estimates and assumptions, which affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reporting period. Accordingly, actual results may differ from those estimates.

Reclassifications. Prior period financial statement amounts have been reclassified to conform to current period presentation. The reclassifications have no effect on net loss or earnings per share.

Recent Accounting Pronouncements.

Management has considered all recent accounting pronouncements in the current period and identified no pronouncements that would have an impact on our financial statements.

-7-

4. INVESTMENTS

In December 2018, the Company acquired a 15% interest in Preprogen LLC pursuant to the Preprogen Transaction. On October 8, 2018, the Preprogen Agreement was amended to provide for, among other things, the release of funds held in escrow related to the manufacture of the miniform pads (the “Preprogen Amendment”), which resulted in both parties receiving $200,583 in cash. As consideration for the Preprogen Amendment, the Company agreed to pay Preprogen a royalty of 5% from the sale of all over-the-counter miniform products; provided, however, that such royalty payments shall terminate when Preprogen has received $200,000 in aggregate consideration from the royalties paid by us, and that we shall be entitled to offset such royalty payments due and payable to Preprogen by amounts equal to certain other payments otherwise due and payable to us by Preprogen pursuant to the terms of the Preprogen Agreement. At December 31, 2019, we had fully impaired our investment in Preprogen.

5. INTANGIBLE ASSETS

On December 15, 2017, the Company entered into an agreement with Preprogen, pursuant to which the parties agreed to the sale, assignment, and license-back of certain assets, including intellectual property transferred to Preprogen necessary to the development, manufacture, marketing and sale of the Company’s OTC miniform products for the feminine hygiene and hemorrhoid treatment markets. At December 31, 2019, the Company had reduced its capitalized intangible assets to zero.

6. CONVERTIBLE NOTES PAYABLE

During the years 2014 to 2017, the Company issued a series of Bridge Notes (the “Bridge Notes”) in aggregate principal amount of $1,489,694. The Bridge Notes matured on various dates through 2018. The Bridge Notes are in default and bear interest rates ranging from 12% to 18%. As of September 30, 2021, the Bridge Notes are due and payable.

At September 30, 2021 and December 31, 2020, the Company’s Convertible Notes Payable are as follows:

	September 30, 2021		December 31, 2020
Notes Payable	$	1,387,694	$	1,387,694
Accrued Interest	$	1,017,012	$	866,226
Notes Payable, related party	$	102,000	$	102,000
Accrued Interest, related Party	$	75,649	$	64,251
Total Notes Payable	$	2,582,355	$	2,420,171

Notes Payable, Related Party.

As of September 30, 2021 and December 31, 2020, the Company owed Mr. Abrams, a director of the Company, an aggregate total of $177,649 and $166,251, respectively, for outstanding principal and accrued and unpaid interest on certain Bridge Notes. The Bridge Notes held by Mr. Abrams are in default and bear interest rates ranging from 12% to 18%. As of September 30, 2021, the Bridge Notes are due and payable.

7. RELATED PARTY TRANSACTIONS

In November 2018, the Company authorized payment of $3,500 per month to Dr. Hirschman for his services as Chief Executive Officer and $3,500 to Mr. Abrams for his services as a Director. Effective January 1, 2020, Mr. Abrams has waived the payments of fees for his services. Effective April 1, 2020, Dr. Hirschman has waived the payment of is fees as Chief Executive Officer.

During the nine months ended September 30, 2020, Dr. Hirschman received aggregate compensation of $3,500 of consulting fees for services as Chief Executive Officer. The Company applied $7,000 of prepaid consulting fees to services for February and March 2020.

During the nine months ended September 30, 2020, Mr. Abrams received payment of accrued consulting fees for services during 2019 in the amount of $14,085. Subsequent to September 30, 2020, Mr. Abrams did not receive or accrue new compensation as he has waived his compensation for services as a Director.

-8-

8. PREFERRED STOCK

The Company has authorized 25,000,000 shares of Preferred Stock, of which 20,500,000 are designated as Series B Convertible Preferred Stock, $0.01 par value, with a stated value of approximately $204,000 (“Series B Preferred”). The remaining authorized preferred shares had not been designated by the Company as of September 30, 2021.

Series B Convertible Preferred Stock

The Series B Preferred ranks senior to the Company’s Common Stock for purposes of liquidation preference, and to all other classes and series of equity securities of the Company that by their terms did not rank senior to the Series B Preferred (“Junior Stock”). Holders of the Series B Preferred are entitled to receive cash dividends, when, as and if declared by the Board of Directors, and they shall be entitled to receive an amount equal to the cash dividend declared on one share of Common Stock multiplied by the number of shares of Common Stock equal to the outstanding shares of Series B Preferred, on an as converted basis. The holders of Series B Preferred have voting rights to vote as a class on matters (a) amending, altering or repealing the provisions of the Series B Preferred so as to adversely affect any right, preference, privilege or voting power of the Series B Preferred; or (b) to affect any distribution with respect to Junior Stock. At any time, the holders of Series B Preferred may, subject to limitations, elect to convert all or any portion of their Series B Preferred into fully paid non-assessable shares of the Company’s Common Stock at a 1:1 conversion rate.

In July and August 2017, the Company entered into Note Purchase Agreements with two existing stockholders, pursuant to which the Company issued the 2017 Bridge Notes in the aggregate principal amount of $86,000. As additional consideration for the purchase of the 2017 Bridge Notes, the Company has reserved for issuance an aggregate of 860,000 shares of Series B Preferred to be issued to the purchasers of the 2017 Bridge Notes. The Company has valued the Series B Preferred and has recorded a discount on the 2017 Bridge Notes of $7,818, which was amortized in full during the year ended December 31, 2017.

In April 2018, the Company completed the purchase of 10,480,049 shares of Series B Preferred (the “Purchased Shares”) from an institutional shareholder for an aggregate purchase price of $20,000. Following this transaction, the shareholder no longer holds shares in the Company.

As of September 30, 2021 and December 31, 2020, the Company had 6,196,893 shares of Series B Preferred issued and outstanding, with a liquidation preference of $61,969 and convertible into 6,196,893 shares of the Company’s Common Stock.

9. COMMON STOCK, OPTIONS AND WARRANTS

The Company has authorized 150,000,000 shares of its Common Stock for issuance, of which 78,696,461 were issued and outstanding at each September 30, 2021 and December 31, 2020.

During the nine months ended September 30, 2021 and 2020, there were no warrants issued by the Company. As of September 30, 2021, the Company has one warrant issued and outstanding, this warrant was issued in December 2018 to Preprogen’s designee to purchase up to 15.0 million shares of the Company’s Common Stock, at an exercise price of $0.05 per share. The warrant was exercisable immediately upon issuance, and expires on December 14, 2022.

2007 Incentive and Non-Qualified Stock Option Plan. The fair value of options granted under the Company’s 2007 Incentive and Non-Qualified Stock Option Plan is recorded as compensation expense over the vesting period, or, for performance based awards, the expected service term. The Company did not issue any options during the nine months ended September 30, 2021 or 2020. As of September 30, 2021, the Company has no options issued and outstanding.

10. SUBSEQUENT EVENTS

We have evaluated subsequent events through the date of this filing in accordance with the Subsequent Events Topic of the FASB ASC 855, and have determined that no subsequent events occurred that are reasonably likely to impact these financial statements.

-9-

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our financial condition should be read in conjunction with the financial statements and notes to financial statements included elsewhere in this filing. The following discussion (as well as statements in Item 1 above and elsewhere) contains forward-looking statements within the meaning of the Private Securities Litigation Act of 1995 that involve risks and uncertainties. Some or all of the results anticipated by these forward-looking statements may not occur. Forward-looking statements involve known and unknown risks and uncertainties including, but not limited to, trends in the biotechnology, healthcare, and pharmaceutical sectors of the economy; competitive pressures and technological developments from domestic and foreign genetic research and development organizations which may affect the nature and potential viability of our business strategy; and private or public sector demand for products and services similar to what we plan to commercialize. We disclaim any intention or obligation to publicly announce the results of any revisions to any of the forward-looking statements contained herein to reflect future events or developments.

Unless otherwise indicated or the context otherwise requires, all references in this report to “we”, “our”, “us”, the “Company” or similar terms refer to QuantRx Biomedical Corporation, a Nevada corporation.

Overview

We have developed and intend to commercialize our patented miniform PADs and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses and other medical needs. We are also developing and intend to commercialize genomic diagnostics for the laboratory market, based on our lateral flow patents. Our platforms include: inSync®, UniqueTM, and OEM branded over-the-counter and laboratory testing products based on our core intellectual property related to our PAD technology.

The continuation of our operations remains contingent upon the receipt of additional financing required to execute our business and operating plan, which is currently focused on the commercialization of our PAD technology, either directly or through a joint venture or other relationship intended to increase shareholder value. In the interim, we have nominal operations, focused principally on maintaining our intellectual property portfolio and maintaining compliance with the public company reporting requirements. In order to continue as a going concern, we will need to raise capital, which may include through the issuance of debt and/or equity securities. No assurances can be given that we will be able to obtain additional financing under terms favorable to us, if at all, or otherwise successfully develop a business and operating plan or enter into an alternative relationship to commercialize our PAD technology.

Our principal business line consists of over-the-counter commercialization of our InSync feminine hygienic interlabial pad, the Unique® Miniform for hemorrhoid application, and other treated miniforms (the “OTC Business”), as well as maintaining established and continuing licensing relationships related to the OTC Business. We also own certain diagnostic testing technology (the “Diagnostic Business”, and with the OTC Business, the “Businesses”) that is based on our lateral flow patents. Management believes this corporate structure permits us to more efficiently explore options to maximize the value of the Businesses, with the objective of maximizing the value of the Businesses for the benefit of the Company and our shareholders.

Our current focus is to obtain additional working capital necessary to continue as a going concern, and to develop a longer term financing and operating plan to: (i) commercialize our over-the-counter products either directly or through joint ventures, mergers or similar transactions intended to capitalize on potential commercial opportunities; (ii) contract manufacturing of our over-the-counter products to third parties while maintaining control over the manufacturing process; (iii) maintain our intellectual property portfolio with respect to patents and licenses pertaining to both the OTC Business and the Diagnostics Business; and (iv) maximize the value of our investments in non-core assets. As a result of our current financial condition, however, our efforts in the short-term will be focused on obtaining financing necessary to maintain the Company as a going concern.

While we expect the impacts of COVID-19 to have an adverse effect on our ability to successfully obtain working capital necessary to continue as a going concern and to develop a longer term financing and operating plan, we are unable to predict the extent or nature of these impacts at this time.

The following discussion of our financial condition should be read together with our financial statements and related notes included in the Annual Report on Form 10-K, filed on April 15, 2021.

-10-

Results of Operations

Comparison of the Three and Nine Months Ended September 30, 2021 to the Three and Nine Months Ended September 30, 2020.

The Company did not generate any revenue during the three and nine months ended September 30, 2021 or the three and nine months ended September 30, 2020. The absence of revenue is due to no royalty revenue attributable to the Company’s PAD technology received during the periods. Management does not anticipate that the Company will generate any revenue until such time as the Company develops a plan to commercialize its over-the-counter products, which is contingent on the receipt of financing.

Sales, general and administrative expense for the three months ended September 30, 2021 and 2020 was $2,810 and $1,908, respectively. Sales, general and administrative expense for the nine months ended September 30, 2021 and 2020 was $9,457 and $8,797, respectively. Sales, general and administrative expense includes, but is not limited to, consulting expense, office and insurance expense, accounting and other costs to maintain compliance with the Company’s reporting requirements to the Securities and Exchange Commission (the “SEC”). The increase in the 2021 three and nine months are due primarily to increased costs by the Company’s stock transfer agent.

Professional fees for the three months ended September 30, 2021 and 2020 were $5,732 and $8,874, respectively. Professional fees for the nine months ended September 30, 2021 and 2020 were $27,363 and $32,235, respectively. Professional fees include the costs of legal, consulting and auditing services provided to us. The decrease in professional fees for the three and nine months ended September 30, 2021 relate to lower legal expenses in the 2021 period compared to the 2020 period.

Professional fees, related party for the three months ended September 30, 2021 and 2020 were $0 and $0, respectively. Professional fees, related party for the nine months ended September 30, 2021 and 2020 were $0 and $10,500, respectively. The decrease in these professional fees relate to lower fees paid to Dr. Hirschman for services to the Company, as Dr. Hirschman waived consulting fees effective April 1, 2020, and Mr. Abrams has waived consulting fees effective January 1, 2020.

The Company did not incur any research and development costs during the three or nine months ended September 30, 2021 or 2020. The Company did not engage in any research and development efforts in the 2020 period, nor does the Company expect to engage in any research and development activity until funding is secured and it develops a plan to commercialize its products.

Interest expense for the three months ended September 30, 2021 and 2020 was $54,473 and $54,474, respectively. Interest expense for the nine months ended September 30, 2021 and 2020 was $162,183 and $162,247, respectively. The decrease in interest expense during the three months ended September 30, 2021 is due to timing. The decrease in interest expense in the nine months ended September 30, 2021 is due to interest on insurance financing during the 2020 period.

During the nine months ended September 30, 2020, the Company recorded a gain on forgiveness of accounts payable in aggregate amount of $24,610 resulting from one of the Company’s vendors forgiving its fees due for professional services incurred through December 31, 2019.

During the three months ended September 30, 2021, the Company recorded net loss of $63,015 compared to net loss for the three months ended September 30, 2020 of $65,166. During the nine months ended September 30, 2021, the Company recorded net loss of $199,003 compared to net loss for the nine months ended September 30, 2020 of $189,169 The decrease in net loss during the three months ended September 30, 2021 is due primarily to lower expenses in the 2021 period. The increase in net loss during the nine month periods in 2021 is primarily due to the gain recorded in the 2020 period and overall lower expenses during the 2021 period, as discussed above.

The Company expects net loss to decrease in future periods due to the current suspension of its active operations and its lack of revenue. The Company does not expect to re-commence active operations until it is able to secure financing necessary to execute its business and operating plan, including the development and launch of its over-the-counter products, or to otherwise capitalize on our PAD technology.

-11-

Liquidity and Capital Resources

At September 30, 2021, the Company had cash and cash equivalents of $21,051 as compared to $55,428 at December 31, 2020.

The Company had cash and cash equivalents of $61,266 at September 30, 2020. The decrease in cash and cash equivalents between the 2021 and 2020 periods of approximately $40,215 is primarily attributable to cash used for operations in the 2020 and 2021 periods.

During the nine months ended September 30, 2021, the Company used $34,377 for operating activities, compared to $69,085 used during the nine months ended September 30, 2020. The net overall decrease in cash used for operating activities during the nine months ended September 30, 2021 is attributable primarily to decreased operating expenses in the in the 2021 period.

The Company has not generated sufficient revenue from operations to meet its operating expense. The Company requires additional funding to complete the development and launch of its over-the-counter products, or to otherwise capitalize on its PAD technology. The Company has historically financed its operations primarily through issuances of equity and the proceeds of debt instruments. In the past, the Company has also provided for its cash needs by issuing shares of its Common Stock, options and warrants for certain operating costs, including consulting and professional fees. In addition, in the fiscal year ended December 31, 2018, the Company received a large cash payment from Preprogen as consideration for the sale and transfer of the certain assets.

Management believes that given the current economic environment and the continuing need to strengthen our cash position, there is substantial doubt about our ability to continue as a going concern. We are pursuing various funding options, including licensing opportunities and the sale of investment holdings, as well other financing transactions, to obtain additional funding to continue the development of our products and bring them to commercial markets. There can be no assurance that we will be successful in our efforts. Should we be unable to raise adequate financing or generate sufficient revenue in the future, the Company’s business, results of operations, liquidity and financial condition would be materially and adversely harmed.

The Company believes that the ability of the Company to re-commence operations, and therefore continue as a going concern is dependent upon its ability to do any or all of the following:

●

obtain adequate sources of funding to pay operating expense and fund long-term business operations;

●

enter into a licensing or other relationship that allows the Company to commercialize its products;

●

manage or control working capital requirements by reducing operating expense; and

●

develop new, and enhance existing, relationships with product distributors and other points of distribution for the Company’s products.

There can be no assurance that the Company will be successful in achieving its short- or long-term plans as set forth above, or that such plans, if consummated, will enable the Company to obtain profitable operations or continue in the long-term as a going concern.

Off-Balance Sheet Arrangements

We have not entered into any transactions with unconsolidated entities in which we have financial guarantees, subordinated retained interests, derivative instruments or other contingent arrangements that expose us to material continuing risks, contingent liabilities or any other obligations under a variable interest in an unconsolidated entity that provides us with financing, liquidity, market risk or credit risk support.

Critical Accounting Policies

The listing below is not intended to be a comprehensive list of all of our accounting policies. In most cases, the accounting treatment of a particular transaction is specifically dictated by accounting principles generally accepted in the United States. In addition to the listing below accounting policies listed below, please See to Note 3 to the Financial Statements.

-12-

Impairment of Assets

We assess the impairment of long-lived assets, including our other intangible assets, at least annually or whenever events or changes in circumstances indicate that their carrying value may not be recoverable. The determination of related estimated useful lives and whether or not these assets are impaired involves significant judgments, related primarily to the future profitability and/or future value of the assets. Changes in our strategic plan and/or market conditions could significantly impact these judgments and could require adjustments to recorded asset balances. We hold investments in companies having operations or technologies in areas which are within or adjacent to our strategic focus when acquired, all of which are privately held and whose values are difficult to determine. We record an investment impairment charge if we believe an investment has experienced a decline in value that is other than temporary. Future changes in our strategic direction, adverse changes in market conditions or poor operating results of underlying investments could result in losses or an inability to recover the carrying value of the investments that may not be reflected in an investment’s current carrying value, thereby possibly requiring an impairment charge in the future.

In determining fair value of assets, the Company bases estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about carrying values of assets that are not readily apparent from other sources. Actual fair value may differ from management estimates resulting in potential impairments causing material changes to certain assets and results of operations.

Genomics USA, Inc. (“GUSA”): During the years ended December 31, 2018 and 2017, the Company had recorded losses of $0 and $169,948, respectively, on an impairment on the value of its Common Stock investment in GUSA. The Company has valued the impairment based on the dilution of the Company’s investment and certain other factors. As of December 31, 2018, the Company has fully impaired its investment in GUSA.

Global Cancer Diagnostics, Inc. (“GCD”): During 2015, the Company entered into a letter of intent with GCD, which provided for, among other things, the advance payment of $50,000 towards a potential business combination. During 2017, the Company determined the full amount of the advanced payment to be impaired.

Preprogen: During the years ended December 31, 2019 and December 31, 2018, the Company recorded a loss of $222,000 and $278,000, respectively, on an impairment on the value of its investment in Preprogen. The Company has valued the impairment based on an evaluation by a third-party using the value of similar investments in comparable companies. The Company has fully impaired its investment in Preprogen.

Deferred Taxes

We recognize deferred tax assets and liabilities based on differences between the financial statement carrying amounts and tax bases of assets and liabilities, which requires management to perform estimates of future transactions and their respective valuations. We review our deferred tax assets for recoverability and establish a valuation allowance if it is more likely than not that the Company will not realize the benefit of the net deferred tax asset. At June 30, 2021 and December 31, 2020, a valuation allowance has been established. The likelihood of a material change in the valuation allowance depends on our ability to generate sufficient future taxable income. In the future, if management determines that the likelihood exists to utilize the Company’s deferred tax assets, a reduction of the valuation allowance could materially increase the Company’s net deferred tax asset.

ITEM 4. Controls and Procedures

(a) Evaluation of disclosure controls and procedures.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operations of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of September 30, 2021. Based on this evaluation, and in light of the previously disclosed material weaknesses in internal controls over financial reporting, the Company’s Chief Executive Officer, who also serves as its Principal Financial Officer, concluded that our disclosure controls and procedures were not effective.

(b) Changes in internal controls over financial reporting.

There has been no change in our internal control over financial reporting that occurred during our most recent fiscal year that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. There has been no progress towards remediating our previously disclosed material weakness due to the lack of funding.

-13-

PART II - OTHER INFORMATION

ITEM 1. Legal Proceedings

As of the date hereof, there are no material pending legal proceedings to which we are a party to or of which any of our property is the subject.

ITEM 1A. Risk Factors

Our results of operations and financial condition are subject to numerous risks and uncertainties described in our Annual Report on Form 10-K for our fiscal year ended December 31, 2020, filed on April 15, 2021. You should carefully consider these risk factors in conjunction with the other information contained in this Quarterly Report. Should any of these risks materialize, our business, financial condition and future prospects could be negatively impacted. As of September 30, 2021, there have been no material changes to the disclosures made in the above-referenced Form 10-K.

ITEM 2. Unregistered Sales of Equity Securities, and Use of Proceeds

None.

ITEM 3. Defaults Upon Senior Securities

None.

ITEM 4. Mine Safety Disclosures

Not Applicable.

ITEM 5. Other Information

None.

ITEM 6. Exhibits

Exhibit		Description
31		Certification of Chief Executive Officer and Principal Financial and Accounting Officer required under Rule 13a-14(a) or Rule 15d-14(a) of the Securities and Exchange Act of 1934, as amended.
32		Certification of Chief Executive Officer and Principal Financial and Accounting Officer required under Rule 13a-14(a) or Rule 15d-14(a) of the Securities and Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350.
101.INS		Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (embedded within the Inline XBRL Document and included in Exhibit 101)

-14-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: November 16, 2021

/s/ Shalom Hirschman

Shalom Hirschman

Principal Executive, Financial and Accounting Officer

-15-

EX-31 2 ex_305054.htm EXHIBIT 31 ex_305054.htm

Exhibit 31

CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO EXCHANGE ACT RULE 13A-14(A)

I, Shalom Hirschman, certify that:

1. I have reviewed this Quarterly report on Form 10-Q of QuantRx Biomedical Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financing reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 16, 2021

/s/ Shalom Hirschman

Shalom Hirschman

Principal Executive and Financial Officer

EX-32 3 ex_305055.htm EXHIBIT 32 ex_305055.htm

Exhibit 32

CERTIFICATION PURSUANT TO 18 U.S.C. Sec.1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the accompanying Quarterly Report of QuantRx Biomedical Corporation (the "Company") on Form 10-Q for the period ending September 30, 2021 as filed with the Securities and Exchange Commission on or about the date hereof (the "Report"), the undersigned, Shalom Hirschman, Principal Executive and Principal Financial and Accounting Officer of the Company, certifies, to my best knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: November 16, 2021

/s/ Shalom Hirschman

Shalom Hirschman

Principal Executive and Financial Officer

EX-101.SCH 4 qtxb-20210930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Statements of Operations (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Statements of Stockholders' Equity (Unaudited) link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Description of Business and Basis of Presentation link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Management Statement Regarding Going Concern link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Investments link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Intangible Assets link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 6 - Convertible Notes Payable link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - Preferred Stock link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 9 - Common Stock, Options and Warrants link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 10 - Subsequent Events link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 6 - Convertible Notes Payable (Tables) link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 4 - Investments (Details Textual) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 6 - Convertible Notes Payable (Details Textual) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 6 - Convertible Notes Payable (Details) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 8 - Preferred Stock (Details Textual) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 9 - Common Stock, Options and Warrants (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 5 qtxb-20210930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 6 qtxb-20210930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 7 qtxb-20210930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Fair Value Measurement, Policy [Policy Text Block] Note To Financial Statement Details Textual Provision for Income Taxes Reclassifications [Policy Text Block] Represents reclassifications. Significant Accounting Policies Equity Option [Member] Note 6 - Convertible Notes Payable Additional Paid-in Capital [Member] Investments, net of impairment of $500,000 Note 6 - Convertible Notes Payable (Details) Accrued interest Common Stock [Member] Notes To Financial Statements Related Party Transactions Disclosure [Text Block] Preferred Stock [Member] Notes To Financial Statements [Abstract] Debt Disclosure [Table Text Block[ Represents debt disclosure table text block. Equity Components [Axis] Equity Component [Domain] us-gaap_ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense, Total Earnings Per Share, Policy [Policy Text Block] us-gaap_PaymentForManagementFee Payment for Management Fee Total Notes Payable Accounts Payable us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Profit (Loss) Before Taxes Stock to be Issued [Member] Represents stock to be issued. Warrents [Member] Represents warrents. Cash and cash equivalents Preferred Shares [Member] Represents preferred shares. Intangible Assets Disclosure [Text Block] Preprogen LLC [Member] Represents Preprogen LLC. Stock to be issued Represents amount of stock to be issued. qtxb_PercentageOfRoyeltyFromSale Percentage of Royelty from Sale Represents the percentage of Royelty from sale. us-gaap_AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense qtxb_MaximumAggregateConsiderationFromRoyalty Maximum Aggregate Consideration from Royalty Represents maximum aggregate consideration from Royalty. Date Ranges [Member] Represents date ranges. us-gaap_AssetsCurrent Total Current Assets us-gaap_DebtInstrumentConvertibleConversionRatio1 Debt Instrument, Convertible, Conversion Ratio Notes Payable, related party qtxb_MinorityInterestPercentage Minority Interest Percentage Represents minority interest percentage. Notes Payable Share-based Payment Arrangement [Policy Text Block] Stockholders' Equity Note Disclosure [Text Block] Chief Executive Officers [Member] Represents chief executive officers. Bridge Notes Two Zero One Seven [Member] Represents bridge notes two zero one seven. qtxb_InterestRate Interest Rate Represents interest rate. Directors [Member] Represents directors. us-gaap_DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount, Total Document Quarterly Report Accrued Interest, related Party Represents other interest payable current. Amendment Flag Entity Incorporation, State or Country Code Accounting Policies [Abstract] Significant Accounting Policies [Text Block] Document Transition Report City Area Code Use of Estimates, Policy [Policy Text Block] qtxb_PreferredStockPurchasedShares Preferred Stock Purchased Shares (in shares) Represents Preferred stock purchased shares. New Accounting Pronouncements, Policy [Policy Text Block] qtxb_AggregatePurchasePrice Aggregate Purchase Price Represents aggregate purchase price. Common stock; $0.01 par value; 150,000,000 authorized; 78,696,461 shares issued and outstanding Entity Interactive Data Current Warrants [Member] Represents warrants. Financial Instruments [Domain] Adjustments to reconcile net loss to net cash used by operating activities: us-gaap_DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal Common stock, authorized (in shares) Common Stock, Shares Authorized (in shares) us-gaap_SharesOutstanding BALANCE (in shares) BALANCE (in shares) Common stock, outstanding (in shares) Common Stock, Shares, Outstanding, Ending Balance (in shares) Title of 12(g) Security Preferred stock, Outstanding (in shares) Preferred Stock, Shares Outstanding, Ending Balance (in shares) Common stock, issued (in shares) Common Stock, Shares, Issued, Total (in shares) Financial Instrument [Axis] Common stock, par value (in dollars per share) Current Fiscal Year End Date us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (in dollars per share) Increase (Decrease) in: us-gaap_DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage us-gaap_CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance (in shares) Statistical Measurement [Domain] Maximum [Member] Accrued interest on notes payable Accrued Interest Document Fiscal Period Focus Minimum [Member] Document Fiscal Year Focus Accounts payable us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance (in shares) Dr. Hirschman, CEO [Member] Represents CEO, Dr. Hirschman. Document Period End Date Mr. Abrams [Member] Represents director, Mr. Abrams. Statistical Measurement [Axis] us-gaap_IncreaseDecreaseInPrepaidExpense Prepaid expense Entity File Number us-gaap_PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value Entity Emerging Growth Company Document Type Gain (loss) on forgiveness of accounts payable Loss (gain) on forgiveness of accounts payable Preferred stock; $0.01 par value, 25,000,000 authorized shares; 20,500,000 shares designated as Series B Convertible Preferred Stock; Series B Convertible Preferred shares 6,196,893 issued and outstanding Entity Small Business Preferred stock, Issued (in shares) Preferred Stock, Shares Issued, Total (in shares) us-gaap_CapitalUnits Capital Units, Value Entity Shell Company Interest expense paid in cash us-gaap_PolicyTextBlockAbstract Accounting Policies Document Information [Line Items] Document Information [Table] Preferred Stock, Shares Authorized (in shares) Preferred Stock, Shares Authorized (in shares) Entity Filer Category Debt Instrument [Axis] Entity Current Reporting Status Debt Instrument, Name [Domain] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share (in dollars per share) Basic and Diluted Weighted Average Shares Used in per Share Calculation (in shares) us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) Bridge Notes [Member] Represents the Company's Bridge Notes information. Income tax paid Entity Tax Identification Number Basic and Diluted Net Loss per Common Share (in dollars per share) Entity Central Index Key Entity Registrant Name us-gaap_PreferredStockCapitalSharesReservedForFutureIssuance Preferred Stock, Capital Shares Reserved for Future Issuance (in shares) Current Liabilities: Entity [Domain] Legal Entity [Axis] Statement [Table] Notes Payable, related party and accrued interest Notes Payable, Related Parties, Current Entity Address, Address Line One Statement of Financial Position [Abstract] Supplemental Cash Flow Disclosures: us-gaap_Assets Total Assets Entity Address, City or Town Preferred Stock [Text Block] Entity Address, Postal Zip Code Entity Address, State or Province CASH FLOWS FROM OPERATING ACTIVITIES Statement of Cash Flows [Abstract] Investment [Text Block] Statement [Line Items] Entity Common Stock, Shares Outstanding Statement of Stockholders' Equity [Abstract] Income Statement [Abstract] Additional paid-in capital Professional fees Stockholders’ Equity (Deficit): Equity Interest Type [Axis] us-gaap_OtherNonoperatingIncomeExpense Total Other Income (Expense), net Equity Interest Issued or Issuable, Type [Domain] Managing Member or General Partner [Axis] Incentive Distribution, Recipient [Domain] Business Description and Basis of Presentation [Text Block] us-gaap_EscrowDeposit Escrow Deposit Current Assets: us-gaap_SaleOfStockPricePerShare Sale of Stock, Price Per Share (in dollars per share) Local Phone Number Net loss Net Profit (Loss) us-gaap_TableTextBlock Notes Tables us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash and Cash Equivalents, Beginning of Period Cash and Cash Equivalents, End of Period us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Net Increase (Decrease) in Cash and Cash Equivalents Net Cash Provided (Used) by Financing Activities us-gaap_Liabilities Total Liabilities Commitments and Contingencies Related Party [Axis] Related Party [Domain] us-gaap_OperatingIncomeLoss LOSS FROM OPERATIONS: Other Income (Expense): us-gaap_NetCashProvidedByUsedInOperatingActivities Net Cash Used by Operating Activities Net Cash Provided by Investing Activities Sales, general and administrative us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) CASH FLOWS FROM FINANCING ACTIVITIES us-gaap_LiabilitiesAndStockholdersEquity Total Liabilities and Stockholders’ Equity (Deficit) Related Party Transaction [Axis] Investments, impairment Related Party Transaction [Domain] (Increase) Decrease in: Accumulated deficit Series B Preferred Stock [Member] Debt Disclosure [Text Block] us-gaap_InterestExpense Interest Expense us-gaap_StockholdersEquity Total Stockholders’ Equity (Deficit) BALANCE BALANCE us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Substantial Doubt about Going Concern [Text Block] us-gaap_CostsAndExpenses Total Costs and Operating Expenses Class of Stock [Axis] Class of Stock [Domain] Costs and Operating Expense: CASH FLOWS FROM INVESTING ACTIVITIES Subsequent Events [Text Block] Professional fees, related party Related Party Costs Retained Earnings [Member] EX-101.PRE 8 qtxb-20210930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 9 quan20210930_10q_htm.xml IDEA: XBRL DOCUMENT 0000820608 2021-01-01 2021-09-30 0000820608 2021-11-15 0000820608 2021-09-30 0000820608 2020-12-31 0000820608 2020-01-01 2020-12-31 0000820608 us-gaap:SeriesBPreferredStockMember 2021-09-30 0000820608 us-gaap:SeriesBPreferredStockMember 2020-12-31 0000820608 2021-07-01 2021-09-30 0000820608 2020-07-01 2020-09-30 0000820608 2020-01-01 2020-09-30 0000820608 2019-12-31 0000820608 2020-09-30 0000820608 qtxb:PreferredSharesMember us-gaap:PreferredStockMember 2020-06-30 0000820608 us-gaap:CommonStockMember 2020-06-30 0000820608 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000820608 qtxb:StockToBeIssuedMember 2020-06-30 0000820608 us-gaap:RetainedEarningsMember 2020-06-30 0000820608 2020-06-30 0000820608 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0000820608 qtxb:PreferredSharesMember us-gaap:PreferredStockMember 2020-09-30 0000820608 us-gaap:CommonStockMember 2020-09-30 0000820608 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0000820608 qtxb:StockToBeIssuedMember 2020-09-30 0000820608 us-gaap:RetainedEarningsMember 2020-09-30 0000820608 qtxb:PreferredSharesMember us-gaap:PreferredStockMember 2019-12-31 0000820608 us-gaap:CommonStockMember 2019-12-31 0000820608 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000820608 qtxb:StockToBeIssuedMember 2019-12-31 0000820608 us-gaap:RetainedEarningsMember 2019-12-31 0000820608 qtxb:PreferredSharesMember us-gaap:PreferredStockMember 2021-06-30 0000820608 us-gaap:CommonStockMember 2021-06-30 0000820608 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000820608 qtxb:StockToBeIssuedMember 2021-06-30 0000820608 us-gaap:RetainedEarningsMember 2021-06-30 0000820608 2021-06-30 0000820608 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000820608 qtxb:PreferredSharesMember us-gaap:PreferredStockMember 2021-09-30 0000820608 us-gaap:CommonStockMember 2021-09-30 0000820608 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000820608 qtxb:StockToBeIssuedMember 2021-09-30 0000820608 us-gaap:RetainedEarningsMember 2021-09-30 0000820608 qtxb:PreferredSharesMember us-gaap:PreferredStockMember 2020-12-31 0000820608 us-gaap:CommonStockMember 2020-12-31 0000820608 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000820608 qtxb:StockToBeIssuedMember 2020-12-31 0000820608 us-gaap:RetainedEarningsMember 2020-12-31 0000820608 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0000820608 qtxb:WarrentsMember 2021-01-01 2021-09-30 0000820608 qtxb:PreferredSharesMember 2021-01-01 2021-09-30 0000820608 us-gaap:StockOptionMember 2021-01-01 2021-09-30 0000820608 us-gaap:SeriesBPreferredStockMember 2020-09-30 0000820608 qtxb:PreprogenLLCMember 2018-12-01 2018-12-31 0000820608 qtxb:PreprogenLLCMember 2018-12-31 0000820608 qtxb:DateRangesMember 2021-01-01 2021-09-30 0000820608 srt:MinimumMember 2021-01-01 2021-09-30 0000820608 srt:MaximumMember 2021-01-01 2021-09-30 0000820608 srt:MaximumMember qtxb:BridgeNotesMember 2021-09-30 0000820608 qtxb:DirectorsMember 2021-09-30 0000820608 qtxb:DirectorsMember 2020-12-31 0000820608 srt:MinimumMember qtxb:BridgeNotesMember 2021-09-30 0000820608 qtxb:DrHirschmanCeoMember 2018-11-30 2018-11-30 0000820608 qtxb:MrAbramsMember 2018-11-30 2018-11-30 0000820608 qtxb:ChiefExecutiveOfficersMember 2020-01-01 2020-09-30 0000820608 qtxb:DirectorsMember 2020-01-01 2020-09-30 0000820608 qtxb:DirectorsMember 2020-10-01 2021-09-30 0000820608 qtxb:DirectorsMember 2021-09-30 0000820608 qtxb:DirectorsMember 2020-12-31 0000820608 us-gaap:SeriesBPreferredStockMember 2021-01-01 2021-09-30 0000820608 qtxb:BridgeNotesTwoZeroOneSevenMember 2021-01-01 2021-09-30 0000820608 qtxb:BridgeNotesTwoZeroOneSevenMember 2021-09-30 0000820608 qtxb:BridgeNotesTwoZeroOneSevenMember 2017-12-31 0000820608 us-gaap:SeriesBPreferredStockMember 2018-04-30 0000820608 qtxb:WarrantsMember 2021-01-01 2021-09-30 thunderdome:item iso4217:USD iso4217:USD shares pure 0000820608 QUANTRX BIOMEDICAL CORP false --12-31 Q3 2021

500000

0.01

25000000

20500000

6196893

0.01

150000000

78696461

0.18

1017012

866226

6196893

78696461

10-Q true 2021-09-30 false 000-17119 NV 33-0202574 10190 SW 90th Avenue Tualatin OR 97062 212 980-2235 Yes No Non-accelerated Filer true false false Common Stock, par value $0.01 per share 78696461

21051

55428

21051

55428

21051

55428

18754

16312

1387694

1017012

866226

177649

166251

2601109

2436483

61969

786964

8600 8600

48876398

-52313989

-52114986

-2580058

-2381055

21051

55428

2810

1908

9457

8797

5732

8784

27363

32235

10500

8542

10692

36820

51532

-8542

-10692

-36820

-51532

54473

54474

162183

162247

24610

-54473

-54474

-162183

-137637

-63015

-65166

-199003

-189169

-63015

-65166

-199003

-189169

-0.00

78696461

-199003

-189169

-0

24610

-0

-7000

2442

-24553

162184

162247

-34377

-69085

-34377

-69085

55428

130351

21051

61266

6196893

61969

78696461

786964

48876398

8600

-51986255

-2172993

-65166

6196893

61969

78696461

786964

48876398

8600

-52051421

-2317490

6196893

61969

78696461

786964

48876398

8600

-51862252

-2128321

-189169

6196893

61969

78696461

786964

48876398

8600

-52051421

-2317490

6196893

61969

78696461

786964

48876398

8600

-52250974

-2517043

-63015

6196893

61969

78696461

786964

48876398

8600

-52313989

-2580058

6196893

61969

78696461

786964

48876398

8600

-52114986

-2381055

-199003

6196893

61969

78696461

786964

48876398

8600

-52313989

-2580058

1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION Overview As used in this Quarterly Report on Form 10-Q, the terms “Company”, “we”, “our”, “us”, “QuantRx” or the “Company” refers to QuantRx Biomedical Corporation, unless context otherwise requires. QuantRx Biomedical Corporation was incorporated on December 5, 1986, in the State of Nevada. Our principal business office is located at 10190 SW 90th Avenue, Tualatin, Oregon 97062. We have developed and intend to commercialize our patented miniform pads (“PADs”) and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses and other medical needs. We are also developing and intend to commercialize genomic diagnostics for the laboratory market, based on our lateral flow patents. Our platforms include: inSync®, UniqueTM, and OEM branded over-the-counter and laboratory testing products based on our core intellectual property related to our PAD technology. The continuation of our operations remains contingent upon the receipt of additional financing required to execute our business and operating plan, which is currently focused on the commercialization of our PAD technology either directly or through a joint venture or other relationship intended to increase shareholder value. In the interim, we have nominal operations, focused principally on maintaining our intellectual property portfolio and maintaining compliance with the public company reporting requirements. In order to continue as a going concern, we will need to raise capital, which may include through the issuance of debt and/or equity securities. No assurances can be given that we will be able to obtain additional financing under terms favorable to us, if at all, or otherwise successfully develop a business and operating plan or enter into an alternative relationship to commercialize our PAD technology. Our principal business line consists of over-the-counter commercialization of our InSync feminine hygienic interlabial pad, the Unique® Miniform for hemorrhoid application, and other treated miniforms (the “OTC Business”), as well as maintaining established and continuing licensing relationships related to these products. We also own certain diagnostic testing technology (the “Diagnostic Business”, and collectively with the OTC Business, the "Business") that is based on our lateral flow patents. Management believes this corporate structure permits us to more efficiently explore options to maximize the value of our products and intellectual property portfolio, with the objective of maximizing the value of the Businesses for the benefit of the Company and our shareholders. Our current focus is to obtain additional working capital necessary to continue as a going concern, and to develop a longer term financing and operating plan to: (i) commercialize our over-the-counter products either directly or through joint ventures, mergers or similar transactions intended to capitalize on potential commercial opportunities; (ii) contract manufacturing of our over-the-counter products to third parties while maintaining control over the manufacturing process; (iii) maintain our intellectual property portfolio with respect to patents and licenses pertaining to both the OTC Business and the Diagnostics Business; and (iv) maximize the value of our investments in non-core assets. As a result of our current financial condition, however, our efforts in the short-term will be focused on obtaining financing necessary to maintain the Company as a going concern. We follow the accounting guidance outlined in the Financial Accounting Standards Board Codification guidelines. The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted principles for interim financial information and with the items under Regulation S-X required by the instructions to Form 10-Q. They may not include all information and footnotes required by United States Generally Accepted Accounting Principles (“GAAP”) for complete financial statements. However, except as disclosed herein, there have been no material changes in the information disclosed in the notes to the financial statements for the year ended December 31, 2020 included in the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on April 15, 2021. The interim unaudited financial statements presented herein should be read in conjunction with those financial statements included in the Form 10-K. In the opinion of Management, all adjustments considered necessary for a fair presentation, which unless otherwise disclosed herein, consisting primarily of normal recurring adjustments, have been made. Operating results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on previously reported losses, total assets or stockholders’ equity.

2. MANAGEMENT STATEMENT REGARDING GOING CONCERN We currently are not generating revenue from operations, and do not anticipate generating meaningful revenue from operations or otherwise in the short-term. We have historically financed our operations primarily through issuances of equity and the proceeds from the issuance of promissory notes. In the past, we also provided for our cash needs by issuing Common Stock, options and warrants for certain operating costs, including consulting and professional fees, as well as divesting its minority equity interests and equity-linked investments. In addition, in the fiscal year ended 2018, we received cash payments as consideration for the sale and transfer of the Purchased Assets to Preprogen. Our history of operating losses, limited cash resources and the absence of an operating plan necessary to capitalize on our assets raise substantial doubt about our ability to continue as a going concern absent a strengthening of our cash position. Management is currently pursuing various funding options, including seeking debt or equity financing, licensing opportunities and the sale of certain investment holdings, as well as a strategic, merger or other transaction to obtain additional funding to continue the development of, and to successfully commercialize, our products. There can be no assurance that the Company will be successful in its efforts. Should we be unable to obtain adequate financing or generate sufficient revenue in the future, the Company’s business, result of operations, liquidity and financial condition would be materially and adversely harmed, and we will be unable to continue as a going concern. There can be no assurance that, assuming we are able to strengthen its cash position, we will achieve sufficient revenue or profitable operations to continue as a going concern.

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to GAAP and have been consistently applied in the preparation of the financial statements. Accounting for Share-Based Payments. The Company follows the provisions of ASC Topic 718, which establishes the accounting for transactions in which an entity exchanges equity securities for services and requires companies to expense the estimated fair value of these awards over the requisite service period. The Company uses the Black-Scholes option pricing model in determining fair value. Accordingly, compensation cost has been recognized using the fair value method and expected term accrual requirements as prescribed. During the three and nine months ended September 30, 2021 and 2020, the Company had no stock compensation expense. In June 2018, the FASB issued an accounting pronouncement (FASB ASU 2018-07) to expand the scope of ASC Topic 718, Compensation - Stock Compensation, to include share-based payment transactions for acquiring goods and services from nonemployees. The pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2018, with early adoption permitted (for “emerging growth company” beginning after December 15, 2019). The Company has adopted this standard effective from January 1, 2020 and the adoption of this standard did not have any significant impact on the unaudited condensed consolidated interim financial statements. In the case of modifications, the Black-Scholes model is used to value modified warrants on the modification date by applying the revised assumptions. The difference between the fair value of the warrants prior to the modification and after the modification determines the incremental value. In the past, the Company has modified warrants in connection with the issuance of certain notes and note extensions. These modified warrants were originally issued in connection with previous private placement investments. In the case of debt issuances, the warrants were accounted for as original issuance discount based on their relative fair values. When modified in connection with a note issuance, the Company recognizes the incremental value as a part of the debt discount calculation, using its relative fair value in accordance with ASC Topic 470-20, “Debt with Conversion and Other Options”. When modified in connection with note extensions, the Company recognized the incremental value as prepaid interest, which is expensed over the term of the extension. The fair value of each share-based payment is estimated on the measurement date using the Black-Scholes model with the following assumptions, which are determined at the beginning of each year and utilized in all calculations for that year. During the three and nine months ended September 30, 2021 and 2020, the Company did not make any Black-Scholes model assumptions, as no share-based payments were made during those periods. Risk-Free Interest Rate. The interest rate used is based on the yield of a U.S. Treasury security as of the beginning of the year. Expected Volatility. The Company calculates the expected volatility based on historical volatility of monthly stock prices over a three-year period. Dividend Yield. The Company has never paid cash dividends, and does not currently intend to pay cash dividends, and thus has assumed a 0% dividend yield. Expected Term. For options, the Company has no history of employee exercise patterns. Therefore, the Company uses the option term as the expected term. For warrants, the Company uses the actual term of the warrant. Pre-Vesting Forfeitures. Estimates of pre-vesting option forfeitures are based on Company experience. The Company will adjust its estimate of forfeitures over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from such estimates. Changes in estimated forfeitures will be recognized through a cumulative catch-up adjustment in the period of change and will also impact the amount of compensation expense to be recognized in future periods. Earnings per Share. The Company computes net income (loss) per common share in accordance with ASC Topic 260. Net income (loss) per share is based upon the weighted average number of outstanding common shares and the dilutive effect of common share equivalents, such as options and warrants to purchase common stock, convertible preferred stock and convertible notes, if applicable, that are outstanding each year. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the “treasury stock” and/or “if converted” methods as applicable. For the three and nine months ended September 30, 2021 and the three and nine months ended September 30, 2020, basic and diluted earnings per share were the same at the reporting dates of the accompanying financial statements, as including common stock equivalents in the calculation of diluted earnings per share would have been antidilutive. As of September 30, 2021, the Company has no outstanding options, as all options expired in 2020. As of September 30, 2021, the Company had outstanding warrants exercisable for 15,000,000 shares of its common stock $0.01 par value (“Common Stock”), and outstanding preferred stock, $0.01 par value (“Preferred Stock”) convertible into 6,196,893 shares of its Common Stock, which options, warrants and Preferred Stock were deemed to be antidilutive for the nine months ended September 30, 2021. At September 30, 2021, the Company had reserved for issuance to certain investors 860,000 shares of its Series B Convertible Preferred Stock, convertible into 860,000 shares of its Common Stock. As of September 30, 2020, the Company has estimated and reserved for issuance approximately 20.0 million shares of Common Stock for a future conversion of its issued and outstanding Convertible Notes Payable. As of September 30, 2020, the Company had no outstanding options. As of September 30, 2020, the Company had outstanding warrants exercisable for 15,000,000 shares of its Common Stock, and outstanding Preferred Stock convertible into 6,196,893 shares of its Common Stock, which options, warrants and Preferred Stock were deemed to be antidilutive for the nine months ended September 30, 2020. At September 30, 2020, the Company had reserved for issuance to certain investors 860,000 shares of its Series B Convertible Preferred Stock, convertible into 860,000 shares of its Common Stock. As of September 30, 2020, the Company has estimated and reserved for issuance approximately 20.0 million shares of Common Stock for a future conversion of its issued and outstanding Convertible Notes Payable. Fair Value. The Company has adopted ASC Topic 820, “Fair Value Measurements and Disclosures” for both financial and nonfinancial assets and liabilities. The Company has not elected the fair value option for any of its assets or liabilities. Use of Estimates. The accompanying financial statements are prepared in conformity with accounting principles generally accepted in the United States of America, and include certain estimates and assumptions, which affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reporting period. Accordingly, actual results may differ from those estimates. Reclassifications. Prior period financial statement amounts have been reclassified to conform to current period presentation. The reclassifications have no effect on net loss or earnings per share. Recent Accounting Pronouncements. Management has considered all recent accounting pronouncements in the current period and identified no pronouncements that would have an impact on our financial statements.

Accounting for Share-Based Payments. The Company follows the provisions of ASC Topic 718, which establishes the accounting for transactions in which an entity exchanges equity securities for services and requires companies to expense the estimated fair value of these awards over the requisite service period. The Company uses the Black-Scholes option pricing model in determining fair value. Accordingly, compensation cost has been recognized using the fair value method and expected term accrual requirements as prescribed. During the three and nine months ended September 30, 2021 and 2020, the Company had no stock compensation expense. In June 2018, the FASB issued an accounting pronouncement (FASB ASU 2018-07) to expand the scope of ASC Topic 718, Compensation - Stock Compensation, to include share-based payment transactions for acquiring goods and services from nonemployees. The pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2018, with early adoption permitted (for “emerging growth company” beginning after December 15, 2019). The Company has adopted this standard effective from January 1, 2020 and the adoption of this standard did not have any significant impact on the unaudited condensed consolidated interim financial statements. In the case of modifications, the Black-Scholes model is used to value modified warrants on the modification date by applying the revised assumptions. The difference between the fair value of the warrants prior to the modification and after the modification determines the incremental value. In the past, the Company has modified warrants in connection with the issuance of certain notes and note extensions. These modified warrants were originally issued in connection with previous private placement investments. In the case of debt issuances, the warrants were accounted for as original issuance discount based on their relative fair values. When modified in connection with a note issuance, the Company recognizes the incremental value as a part of the debt discount calculation, using its relative fair value in accordance with ASC Topic 470-20, “Debt with Conversion and Other Options”. When modified in connection with note extensions, the Company recognized the incremental value as prepaid interest, which is expensed over the term of the extension. The fair value of each share-based payment is estimated on the measurement date using the Black-Scholes model with the following assumptions, which are determined at the beginning of each year and utilized in all calculations for that year. During the three and nine months ended September 30, 2021 and 2020, the Company did not make any Black-Scholes model assumptions, as no share-based payments were made during those periods. Risk-Free Interest Rate. The interest rate used is based on the yield of a U.S. Treasury security as of the beginning of the year. Expected Volatility. The Company calculates the expected volatility based on historical volatility of monthly stock prices over a three-year period. Dividend Yield. The Company has never paid cash dividends, and does not currently intend to pay cash dividends, and thus has assumed a 0% dividend yield. Expected Term. For options, the Company has no history of employee exercise patterns. Therefore, the Company uses the option term as the expected term. For warrants, the Company uses the actual term of the warrant. Pre-Vesting Forfeitures. Estimates of pre-vesting option forfeitures are based on Company experience. The Company will adjust its estimate of forfeitures over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from such estimates. Changes in estimated forfeitures will be recognized through a cumulative catch-up adjustment in the period of change and will also impact the amount of compensation expense to be recognized in future periods.

Earnings per Share. The Company computes net income (loss) per common share in accordance with ASC Topic 260. Net income (loss) per share is based upon the weighted average number of outstanding common shares and the dilutive effect of common share equivalents, such as options and warrants to purchase common stock, convertible preferred stock and convertible notes, if applicable, that are outstanding each year. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the “treasury stock” and/or “if converted” methods as applicable. For the three and nine months ended September 30, 2021 and the three and nine months ended September 30, 2020, basic and diluted earnings per share were the same at the reporting dates of the accompanying financial statements, as including common stock equivalents in the calculation of diluted earnings per share would have been antidilutive. As of September 30, 2021, the Company has no outstanding options, as all options expired in 2020. As of September 30, 2021, the Company had outstanding warrants exercisable for 15,000,000 shares of its common stock $0.01 par value (“Common Stock”), and outstanding preferred stock, $0.01 par value (“Preferred Stock”) convertible into 6,196,893 shares of its Common Stock, which options, warrants and Preferred Stock were deemed to be antidilutive for the nine months ended September 30, 2021. At September 30, 2021, the Company had reserved for issuance to certain investors 860,000 shares of its Series B Convertible Preferred Stock, convertible into 860,000 shares of its Common Stock. As of September 30, 2020, the Company has estimated and reserved for issuance approximately 20.0 million shares of Common Stock for a future conversion of its issued and outstanding Convertible Notes Payable. As of September 30, 2020, the Company had no outstanding options. As of September 30, 2020, the Company had outstanding warrants exercisable for 15,000,000 shares of its Common Stock, and outstanding Preferred Stock convertible into 6,196,893 shares of its Common Stock, which options, warrants and Preferred Stock were deemed to be antidilutive for the nine months ended September 30, 2020. At September 30, 2020, the Company had reserved for issuance to certain investors 860,000 shares of its Series B Convertible Preferred Stock, convertible into 860,000 shares of its Common Stock. As of September 30, 2020, the Company has estimated and reserved for issuance approximately 20.0 million shares of Common Stock for a future conversion of its issued and outstanding Convertible Notes Payable.

15000000

0.01

6196893

860000

20000000.0

15000000

6196893

860000

20000000.0

Fair Value. The Company has adopted ASC Topic 820, “Fair Value Measurements and Disclosures” for both financial and nonfinancial assets and liabilities. The Company has not elected the fair value option for any of its assets or liabilities.

Use of Estimates. The accompanying financial statements are prepared in conformity with accounting principles generally accepted in the United States of America, and include certain estimates and assumptions, which affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reporting period. Accordingly, actual results may differ from those estimates.

Reclassifications. Prior period financial statement amounts have been reclassified to conform to current period presentation. The reclassifications have no effect on net loss or earnings per share.

Recent Accounting Pronouncements. Management has considered all recent accounting pronouncements in the current period and identified no pronouncements that would have an impact on our financial statements.

4. INVESTMENTS In December 2018, the Company acquired a 15% interest in Preprogen LLC pursuant to the Preprogen Transaction. On October 8, 2018, the Preprogen Agreement was amended to provide for, among other things, the release of funds held in escrow related to the manufacture of the miniform pads (the “Preprogen Amendment”), which resulted in both parties receiving $200,583 in cash. As consideration for the Preprogen Amendment, the Company agreed to pay Preprogen a royalty of 5% from the sale of all over-the-counter miniform products; provided, however, that such royalty payments shall terminate when Preprogen has received $200,000 in aggregate consideration from the royalties paid by us, and that we shall be entitled to offset such royalty payments due and payable to Preprogen by amounts equal to certain other payments otherwise due and payable to us by Preprogen pursuant to the terms of the Preprogen Agreement. At December 31, 2019, we had fully impaired our investment in Preprogen.

0.15

200583

0.05 200000

5. INTANGIBLE ASSETS On December 15, 2017, the Company entered into an agreement with Preprogen, pursuant to which the parties agreed to the sale, assignment, and license-back of certain assets, including intellectual property transferred to Preprogen necessary to the development, manufacture, marketing and sale of the Company’s OTC miniform products for the feminine hygiene and hemorrhoid treatment markets. At December 31, 2019, the Company had reduced its capitalized intangible assets to zero.

6. CONVERTIBLE NOTES PAYABLE During the years 2014 to 2017, the Company issued a series of Bridge Notes (the “Bridge Notes”) in aggregate principal amount of $1,489,694. The Bridge Notes matured on various dates through 2018. The Bridge Notes are in default and bear interest rates ranging from 12% to 18%. As of September 30, 2021, the Bridge Notes are due and payable. At September 30, 2021 and December 31, 2020, the Company’s Convertible Notes Payable are as follows: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> September 30, 2021 </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> December 31, 2020 </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> Notes Payable </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,387,694</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,387,694</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> Accrued Interest </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,017,012</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">866,226</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> Notes Payable, related party </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">102,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">102,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> Accrued Interest, related Party </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">75,649</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">64,251</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> Total Notes Payable </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,582,355</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,420,171</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> Notes Payable, Related Party. As of September 30, 2021 and December 31, 2020, the Company owed Mr. Abrams, a director of the Company, an aggregate total of $177,649 and $166,251, respectively, for outstanding principal and accrued and unpaid interest on certain Bridge Notes. The Bridge Notes held by Mr. Abrams are in default and bear interest rates ranging from 12% to 18%. As of September 30, 2021, the Bridge Notes are due and payable.

1489694

0.12

0.18

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> September 30, 2021 </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> December 31, 2020 </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> Notes Payable </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,387,694</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,387,694</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> Accrued Interest </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1,017,012</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">866,226</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> Notes Payable, related party </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">102,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">102,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> Accrued Interest, related Party </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">75,649</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">64,251</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> Total Notes Payable </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,582,355</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,420,171</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table>

1387694

102000

75649 64251

2582355

2420171

177649

166251

0.12

7. RELATED PARTY TRANSACTIONS In November 2018, the Company authorized payment of $3,500 per month to Dr. Hirschman for his services as Chief Executive Officer and $3,500 to Mr. Abrams for his services as a Director. Effective January 1, 2020, Mr. Abrams has waived the payments of fees for his services. Effective April 1, 2020, Dr. Hirschman has waived the payment of is fees as Chief Executive Officer. During the nine months ended September 30, 2020, Dr. Hirschman received aggregate compensation of $3,500 of consulting fees for services as Chief Executive Officer. The Company applied $7,000 of prepaid consulting fees to services for February and March 2020. During the nine months ended September 30, 2020, Mr. Abrams received payment of accrued consulting fees for services during 2019 in the amount of $14,085. Subsequent to September 30, 2020, Mr. Abrams did not receive or accrue new compensation as he has waived his compensation for services as a Director. As of September 30, 2021 and December 31, 2020, the Company owed Mr. Abrams, a director of the Company, an aggregate total of $177,649 and $166,251, respectively, for outstanding principal and accrued and unpaid interest on certain Bridge Notes.

3500

7000

14085

177649

166251

8. PREFERRED STOCK The Company has authorized 25,000,000 shares of Preferred Stock, of which 20,500,000 are designated as Series B Convertible Preferred Stock, $0.01 par value, with a stated value of approximately $204,000 (“Series B Preferred”). The remaining authorized preferred shares had not been designated by the Company as of September 30, 2021. Series B Convertible Preferred Stock The Series B Preferred ranks senior to the Company’s Common Stock for purposes of liquidation preference, and to all other classes and series of equity securities of the Company that by their terms did not rank senior to the Series B Preferred (“Junior Stock”). Holders of the Series B Preferred are entitled to receive cash dividends, when, as and if declared by the Board of Directors, and they shall be entitled to receive an amount equal to the cash dividend declared on one share of Common Stock multiplied by the number of shares of Common Stock equal to the outstanding shares of Series B Preferred, on an as converted basis. The holders of Series B Preferred have voting rights to vote as a class on matters (a) amending, altering or repealing the provisions of the Series B Preferred so as to adversely affect any right, preference, privilege or voting power of the Series B Preferred; or (b) to affect any distribution with respect to Junior Stock. At any time, the holders of Series B Preferred may, subject to limitations, elect to convert all or any portion of their Series B Preferred into fully paid non-assessable shares of the Company’s Common Stock at a 1:1 conversion rate. In July and August 2017, the Company entered into Note Purchase Agreements with two existing stockholders, pursuant to which the Company issued the 2017 Bridge Notes in the aggregate principal amount of $86,000. As additional consideration for the purchase of the 2017 Bridge Notes, the Company has reserved for issuance an aggregate of 860,000 shares of Series B Preferred to be issued to the purchasers of the 2017 Bridge Notes. The Company has valued the Series B Preferred and has recorded a discount on the 2017 Bridge Notes of $7,818, which was amortized in full during the year ended December 31, 2017. In April 2018, the Company completed the purchase of 10,480,049 shares of Series B Preferred (the “Purchased Shares”) from an institutional shareholder for an aggregate purchase price of $20,000. Following this transaction, the shareholder no longer holds shares in the Company. As of September 30, 2021 and December 31, 2020, the Company had 6,196,893 shares of Series B Preferred issued and outstanding, with a liquidation preference of $61,969 and convertible into 6,196,893 shares of the Company’s Common Stock.

25000000

20500000

0.01

204000

86000

860000

7818

10480049 20000

6196893

61969

6196893

9. COMMON STOCK, OPTIONS AND WARRANTS The Company has authorized 150,000,000 shares of its Common Stock for issuance, of which 78,696,461 were issued and outstanding at each September 30, 2021 and December 31, 2020. During the nine months ended September 30, 2021 and 2020, there were no warrants issued by the Company. As of September 30, 2021, the Company has one warrant issued and outstanding, this warrant was issued in December 2018 to Preprogen’s designee to purchase up to 15.0 million shares of the Company’s Common Stock, at an exercise price of $0.05 per share. The warrant was exercisable immediately upon issuance, and expires on December 14, 2022. 2007 Incentive and Non-Qualified Stock Option Plan. The fair value of options granted under the Company’s 2007 Incentive and Non-Qualified Stock Option Plan is recorded as compensation expense over the vesting period, or, for performance based awards, the expected service term. The Company did not issue any options during the nine months ended September 30, 2021 or 2020. As of September 30, 2021, the Company has no options issued and outstanding.

150000000

78696461

15000000.0

0.05

10. SUBSEQUENT EVENTS We have evaluated subsequent events through the date of this filing in accordance with the Subsequent Events Topic of the FASB ASC 855, and have determined that no subsequent events occurred that are reasonably likely to impact these financial statements.

XML 10 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Sep. 30, 2021	Nov. 15, 2021
Document Information [Line Items]
Entity Central Index Key	0000820608
Entity Registrant Name	QUANTRX BIOMEDICAL CORP
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2021
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	000-17119
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	33-0202574
Entity Address, Address Line One	10190 SW 90th Avenue
Entity Address, City or Town	Tualatin
Entity Address, State or Province	OR
Entity Address, Postal Zip Code	97062
City Area Code	212
Local Phone Number	980-2235
Entity Current Reporting Status	Yes
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Title of 12(g) Security	Common Stock, par value $0.01 per share
Entity Common Stock, Shares Outstanding		78,696,461

XML 11 R2.htm IDEA: XBRL DOCUMENT

Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Current Assets:
Cash and cash equivalents	$ 21,051	$ 55,428
Total Current Assets	21,051	55,428
Investments, net of impairment of $500,000	0	0
Total Assets	21,051	55,428
Current Liabilities:
Accounts payable	18,754	16,312
Notes Payable	1,387,694	1,387,694
Accrued interest on notes payable	1,017,012	866,226
Notes Payable, related party and accrued interest	177,649	166,251
Total Liabilities	2,601,109	2,436,483
Commitments and Contingencies	0	0
Stockholders’ Equity (Deficit):
Preferred stock; $0.01 par value, 25,000,000 authorized shares; 20,500,000 shares designated as Series B Convertible Preferred Stock; Series B Convertible Preferred shares 6,196,893 issued and outstanding	61,969	61,969
Common stock; $0.01 par value; 150,000,000 authorized; 78,696,461 shares issued and outstanding	786,964	786,964
Stock to be issued	8,600	8,600
Additional paid-in capital	48,876,398	48,876,398
Accumulated deficit	(52,313,989)	(52,114,986)
Total Stockholders’ Equity (Deficit)	(2,580,058)	(2,381,055)
Total Liabilities and Stockholders’ Equity (Deficit)	$ 21,051	$ 55,428

XML 12 R3.htm IDEA: XBRL DOCUMENT

Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Investments, impairment	$ 500,000	$ 500,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred Stock, Shares Authorized (in shares)	25,000,000	25,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	150,000,000	150,000,000
Common stock, issued (in shares)	78,696,461	78,696,461
Common stock, outstanding (in shares)	78,696,461	78,696,461
Series B Preferred Stock [Member]
Preferred Stock, Shares Authorized (in shares)	20,500,000	20,500,000
Preferred stock, Issued (in shares)	6,196,893	6,196,893
Preferred stock, Outstanding (in shares)	6,196,893	6,196,893

XML 13 R4.htm IDEA: XBRL DOCUMENT

Statements of Operations (Unaudited) - USD ($) $ / shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Costs and Operating Expense:
Sales, general and administrative	$ 2,810	$ 1,908	$ 9,457	$ 8,797
Professional fees	5,732	8,784	27,363	32,235
Professional fees, related party	0	0	0	10,500
Total Costs and Operating Expenses	8,542	10,692	36,820	51,532
LOSS FROM OPERATIONS:	(8,542)	(10,692)	(36,820)	(51,532)
Other Income (Expense):
Interest Expense	(54,473)	(54,474)	(162,183)	(162,247)
Gain (loss) on forgiveness of accounts payable	0	0	0	24,610
Total Other Income (Expense), net	(54,473)	(54,474)	(162,183)	(137,637)
Profit (Loss) Before Taxes	(63,015)	(65,166)	(199,003)	(189,169)
Provision for Income Taxes	0	0	0	0
Net Profit (Loss)	$ (63,015)	$ (65,166)	$ (199,003)	$ (189,169)
Basic and Diluted Net Loss per Common Share (in dollars per share)	$ (0)	$ (0)	$ (0)	$ (0)
Basic and Diluted Weighted Average Shares Used in per Share Calculation (in shares)	78,696,461	78,696,461	78,696,461	78,696,461

XML 14 R5.htm IDEA: XBRL DOCUMENT

Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (63,015)	$ (65,166)	$ (199,003)	$ (189,169)
Adjustments to reconcile net loss to net cash used by operating activities:
Loss (gain) on forgiveness of accounts payable	0	0	0	(24,610)
(Increase) Decrease in:
Prepaid expense			0	7,000
Increase (Decrease) in:
Accounts Payable			2,442	(24,553)
Accrued interest			162,184	162,247
Net Cash Used by Operating Activities			(34,377)	(69,085)
CASH FLOWS FROM INVESTING ACTIVITIES
Net Cash Provided by Investing Activities			0	0
CASH FLOWS FROM FINANCING ACTIVITIES
Net Cash Provided (Used) by Financing Activities			0	0
Net Increase (Decrease) in Cash and Cash Equivalents			(34,377)	(69,085)
Cash and Cash Equivalents, Beginning of Period			55,428	130,351
Cash and Cash Equivalents, End of Period	$ 21,051	$ 61,266	21,051	61,266
Supplemental Cash Flow Disclosures:
Interest expense paid in cash			0	0
Income tax paid			$ 0	$ 0

XML 15 R6.htm IDEA: XBRL DOCUMENT

Statements of Stockholders' Equity (Unaudited) - USD ($)	Preferred Shares [Member] Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Stock to be Issued [Member]	Retained Earnings [Member]	Total
BALANCE (in shares) at Dec. 31, 2019	6,196,893	78,696,461
BALANCE at Dec. 31, 2019	$ 61,969	$ 786,964	$ 48,876,398	$ 8,600	$ (51,862,252)	$ (2,128,321)
Net loss						(189,169)
BALANCE (in shares) at Sep. 30, 2020	6,196,893	78,696,461
BALANCE at Sep. 30, 2020	$ 61,969	$ 786,964	48,876,398	8,600	(52,051,421)	(2,317,490)
BALANCE (in shares) at Jun. 30, 2020	6,196,893	78,696,461
BALANCE at Jun. 30, 2020	$ 61,969	$ 786,964	48,876,398	8,600	(51,986,255)	(2,172,993)
Net loss					(65,166)	(65,166)
BALANCE (in shares) at Sep. 30, 2020	6,196,893	78,696,461
BALANCE at Sep. 30, 2020	$ 61,969	$ 786,964	48,876,398	8,600	(52,051,421)	(2,317,490)
BALANCE (in shares) at Dec. 31, 2020	6,196,893	78,696,461
BALANCE at Dec. 31, 2020	$ 61,969	$ 786,964	48,876,398	8,600	(52,114,986)	(2,381,055)
Net loss					(199,003)	(199,003)
BALANCE (in shares) at Sep. 30, 2021	6,196,893	78,696,461
BALANCE at Sep. 30, 2021	$ 61,969	$ 786,964	48,876,398	8,600	(52,313,989)	(2,580,058)
BALANCE (in shares) at Jun. 30, 2021	6,196,893	78,696,461
BALANCE at Jun. 30, 2021	$ 61,969	$ 786,964	48,876,398	8,600	(52,250,974)	(2,517,043)
Net loss					(63,015)	(63,015)
BALANCE (in shares) at Sep. 30, 2021	6,196,893	78,696,461
BALANCE at Sep. 30, 2021	$ 61,969	$ 786,964	$ 48,876,398	$ 8,600	$ (52,313,989)	$ (2,580,058)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

XML 16 R7.htm IDEA: XBRL DOCUMENT

Note 1 - Description of Business and Basis of Presentation

9 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Business Description and Basis of Presentation [Text Block]

1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

Overview

XML 17 R8.htm IDEA: XBRL DOCUMENT

Note 2 - Management Statement Regarding Going Concern

9 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Substantial Doubt about Going Concern [Text Block]

2. MANAGEMENT STATEMENT REGARDING GOING CONCERN

There can be no assurance that, assuming we are able to strengthen its cash position, we will achieve sufficient revenue or profitable operations to continue as a going concern.

XML 18 R9.htm IDEA: XBRL DOCUMENT

Note 3 - Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Significant Accounting Policies [Text Block]

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

In June 2018, the FASB issued an accounting pronouncement (FASB ASU 2018-07) to expand the scope of ASC Topic 718, Compensation - Stock Compensation, to include share-based payment transactions for acquiring goods and services from nonemployees. The pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2018, with early adoption permitted (for “emerging growth company” beginning after December 15, 2019). The Company has adopted this standard effective from January 1, 2020 and the adoption of this standard did not have any significant impact on the unaudited condensed consolidated interim financial statements.

In the case of modifications, the Black-Scholes model is used to value modified warrants on the modification date by applying the revised assumptions. The difference between the fair value of the warrants prior to the modification and after the modification determines the incremental value. In the past, the Company has modified warrants in connection with the issuance of certain notes and note extensions. These modified warrants were originally issued in connection with previous private placement investments. In the case of debt issuances, the warrants were accounted for as original issuance discount based on their relative fair values. When modified in connection with a note issuance, the Company recognizes the incremental value as a part of the debt discount calculation, using its relative fair value in accordance with ASC Topic 470-20, “Debt with Conversion and Other Options”. When modified in connection with note extensions, the Company recognized the incremental value as prepaid interest, which is expensed over the term of the extension.

The fair value of each share-based payment is estimated on the measurement date using the Black-Scholes model with the following assumptions, which are determined at the beginning of each year and utilized in all calculations for that year. During the three and nine months ended September 30, 2021 and 2020, the Company did not make any Black-Scholes model assumptions, as no share-based payments were made during those periods.

Risk-Free Interest Rate. The interest rate used is based on the yield of a U.S. Treasury security as of the beginning of the year.

Expected Volatility. The Company calculates the expected volatility based on historical volatility of monthly stock prices over a three-year period.

Dividend Yield. The Company has never paid cash dividends, and does not currently intend to pay cash dividends, and thus has assumed a 0% dividend yield.

Expected Term. For options, the Company has no history of employee exercise patterns. Therefore, the Company uses the option term as the expected term. For warrants, the Company uses the actual term of the warrant.

Pre-Vesting Forfeitures. Estimates of pre-vesting option forfeitures are based on Company experience. The Company will adjust its estimate of forfeitures over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from such estimates. Changes in estimated forfeitures will be recognized through a cumulative catch-up adjustment in the period of change and will also impact the amount of compensation expense to be recognized in future periods.

Earnings per Share. The Company computes net income (loss) per common share in accordance with ASC Topic 260. Net income (loss) per share is based upon the weighted average number of outstanding common shares and the dilutive effect of common share equivalents, such as options and warrants to purchase common stock, convertible preferred stock and convertible notes, if applicable, that are outstanding each year. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the “treasury stock” and/or “if converted” methods as applicable.

For the three and nine months ended September 30, 2021 and the three and nine months ended September 30, 2020, basic and diluted earnings per share were the same at the reporting dates of the accompanying financial statements, as including common stock equivalents in the calculation of diluted earnings per share would have been antidilutive.

As of September 30, 2021, the Company has no outstanding options, as all options expired in 2020. As of September 30, 2021, the Company had outstanding warrants exercisable for 15,000,000 shares of its common stock $0.01 par value (“Common Stock”), and outstanding preferred stock, $0.01 par value (“Preferred Stock”) convertible into 6,196,893 shares of its Common Stock, which options, warrants and Preferred Stock were deemed to be antidilutive for the nine months ended September 30, 2021. At September 30, 2021, the Company had reserved for issuance to certain investors 860,000 shares of its Series B Convertible Preferred Stock, convertible into 860,000 shares of its Common Stock. As of September 30, 2020, the Company has estimated and reserved for issuance approximately 20.0 million shares of Common Stock for a future conversion of its issued and outstanding Convertible Notes Payable.

As of September 30, 2020, the Company had no outstanding options. As of September 30, 2020, the Company had outstanding warrants exercisable for 15,000,000 shares of its Common Stock, and outstanding Preferred Stock convertible into 6,196,893 shares of its Common Stock, which options, warrants and Preferred Stock were deemed to be antidilutive for the nine months ended September 30, 2020. At September 30, 2020, the Company had reserved for issuance to certain investors 860,000 shares of its Series B Convertible Preferred Stock, convertible into 860,000 shares of its Common Stock. As of September 30, 2020, the Company has estimated and reserved for issuance approximately 20.0 million shares of Common Stock for a future conversion of its issued and outstanding Convertible Notes Payable.

Fair Value. The Company has adopted ASC Topic 820, “Fair Value Measurements and Disclosures” for both financial and nonfinancial assets and liabilities. The Company has not elected the fair value option for any of its assets or liabilities.

Use of Estimates. The accompanying financial statements are prepared in conformity with accounting principles generally accepted in the United States of America, and include certain estimates and assumptions, which affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reporting period. Accordingly, actual results may differ from those estimates.

Reclassifications. Prior period financial statement amounts have been reclassified to conform to current period presentation. The reclassifications have no effect on net loss or earnings per share.

Recent Accounting Pronouncements.

Management has considered all recent accounting pronouncements in the current period and identified no pronouncements that would have an impact on our financial statements.

XML 19 R10.htm IDEA: XBRL DOCUMENT

Note 4 - Investments

9 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Investment [Text Block]

4. INVESTMENTS

XML 20 R11.htm IDEA: XBRL DOCUMENT

Note 5 - Intangible Assets

9 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Intangible Assets Disclosure [Text Block]

5. INTANGIBLE ASSETS

XML 21 R12.htm IDEA: XBRL DOCUMENT

Note 6 - Convertible Notes Payable

9 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Debt Disclosure [Text Block]

6. CONVERTIBLE NOTES PAYABLE

At September 30, 2021 and December 31, 2020, the Company’s Convertible Notes Payable are as follows:

	September 30, 2021		December 31, 2020
Notes Payable	$	1,387,694	$	1,387,694
Accrued Interest	$	1,017,012	$	866,226
Notes Payable, related party	$	102,000	$	102,000
Accrued Interest, related Party	$	75,649	$	64,251
Total Notes Payable	$	2,582,355	$	2,420,171

Notes Payable, Related Party.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

XML 22 R13.htm IDEA: XBRL DOCUMENT

Note 7 - Related Party Transactions

9 Months Ended

Sep. 30, 2021

Notes to Financial Statements

7. RELATED PARTY TRANSACTIONS

XML 23 R14.htm IDEA: XBRL DOCUMENT

Note 8 - Preferred Stock

9 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Preferred Stock [Text Block]

8. PREFERRED STOCK

Series B Convertible Preferred Stock

XML 24 R15.htm IDEA: XBRL DOCUMENT

Note 9 - Common Stock, Options and Warrants

9 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Stockholders' Equity Note Disclosure [Text Block]

9. COMMON STOCK, OPTIONS AND WARRANTS

The Company has authorized 150,000,000 shares of its Common Stock for issuance, of which 78,696,461 were issued and outstanding at each September 30, 2021 and December 31, 2020.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

XML 25 R16.htm IDEA: XBRL DOCUMENT

Note 10 - Subsequent Events

9 Months Ended

Sep. 30, 2021

Notes to Financial Statements

Subsequent Events [Text Block]

10. SUBSEQUENT EVENTS

XML 26 R17.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Policies)	9 Months Ended
Significant Accounting Policies (Policies)	Sep. 30, 2021
Accounting Policies [Abstract]
Share-based Payment Arrangement [Policy Text Block]	Accounting for Share-Based Payments. The Company follows the provisions of ASC Topic 718, which establishes the accounting for transactions in which an entity exchanges equity securities for services and requires companies to expense the estimated fair value of these awards over the requisite service period. The Company uses the Black-Scholes option pricing model in determining fair value. Accordingly, compensation cost has been recognized using the fair value method and expected term accrual requirements as prescribed. During the three and nine months ended September 30, 2021 and 2020, the Company had no stock compensation expense. In June 2018, the FASB issued an accounting pronouncement (FASB ASU 2018-07) to expand the scope of ASC Topic 718, Compensation - Stock Compensation, to include share-based payment transactions for acquiring goods and services from nonemployees. The pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2018, with early adoption permitted (for “emerging growth company” beginning after December 15, 2019). The Company has adopted this standard effective from January 1, 2020 and the adoption of this standard did not have any significant impact on the unaudited condensed consolidated interim financial statements. In the case of modifications, the Black-Scholes model is used to value modified warrants on the modification date by applying the revised assumptions. The difference between the fair value of the warrants prior to the modification and after the modification determines the incremental value. In the past, the Company has modified warrants in connection with the issuance of certain notes and note extensions. These modified warrants were originally issued in connection with previous private placement investments. In the case of debt issuances, the warrants were accounted for as original issuance discount based on their relative fair values. When modified in connection with a note issuance, the Company recognizes the incremental value as a part of the debt discount calculation, using its relative fair value in accordance with ASC Topic 470-20, “Debt with Conversion and Other Options”. When modified in connection with note extensions, the Company recognized the incremental value as prepaid interest, which is expensed over the term of the extension. The fair value of each share-based payment is estimated on the measurement date using the Black-Scholes model with the following assumptions, which are determined at the beginning of each year and utilized in all calculations for that year. During the three and nine months ended September 30, 2021 and 2020, the Company did not make any Black-Scholes model assumptions, as no share-based payments were made during those periods. Risk-Free Interest Rate. The interest rate used is based on the yield of a U.S. Treasury security as of the beginning of the year. Expected Volatility. The Company calculates the expected volatility based on historical volatility of monthly stock prices over a three-year period. Dividend Yield. The Company has never paid cash dividends, and does not currently intend to pay cash dividends, and thus has assumed a 0% dividend yield. Expected Term. For options, the Company has no history of employee exercise patterns. Therefore, the Company uses the option term as the expected term. For warrants, the Company uses the actual term of the warrant. Pre-Vesting Forfeitures. Estimates of pre-vesting option forfeitures are based on Company experience. The Company will adjust its estimate of forfeitures over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from such estimates. Changes in estimated forfeitures will be recognized through a cumulative catch-up adjustment in the period of change and will also impact the amount of compensation expense to be recognized in future periods.
Earnings Per Share, Policy [Policy Text Block]	Earnings per Share. The Company computes net income (loss) per common share in accordance with ASC Topic 260. Net income (loss) per share is based upon the weighted average number of outstanding common shares and the dilutive effect of common share equivalents, such as options and warrants to purchase common stock, convertible preferred stock and convertible notes, if applicable, that are outstanding each year. Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the “treasury stock” and/or “if converted” methods as applicable. For the three and nine months ended September 30, 2021 and the three and nine months ended September 30, 2020, basic and diluted earnings per share were the same at the reporting dates of the accompanying financial statements, as including common stock equivalents in the calculation of diluted earnings per share would have been antidilutive. As of September 30, 2021, the Company has no outstanding options, as all options expired in 2020. As of September 30, 2021, the Company had outstanding warrants exercisable for 15,000,000 shares of its common stock $0.01 par value (“Common Stock”), and outstanding preferred stock, $0.01 par value (“Preferred Stock”) convertible into 6,196,893 shares of its Common Stock, which options, warrants and Preferred Stock were deemed to be antidilutive for the nine months ended September 30, 2021. At September 30, 2021, the Company had reserved for issuance to certain investors 860,000 shares of its Series B Convertible Preferred Stock, convertible into 860,000 shares of its Common Stock. As of September 30, 2020, the Company has estimated and reserved for issuance approximately 20.0 million shares of Common Stock for a future conversion of its issued and outstanding Convertible Notes Payable. As of September 30, 2020, the Company had no outstanding options. As of September 30, 2020, the Company had outstanding warrants exercisable for 15,000,000 shares of its Common Stock, and outstanding Preferred Stock convertible into 6,196,893 shares of its Common Stock, which options, warrants and Preferred Stock were deemed to be antidilutive for the nine months ended September 30, 2020. At September 30, 2020, the Company had reserved for issuance to certain investors 860,000 shares of its Series B Convertible Preferred Stock, convertible into 860,000 shares of its Common Stock. As of September 30, 2020, the Company has estimated and reserved for issuance approximately 20.0 million shares of Common Stock for a future conversion of its issued and outstanding Convertible Notes Payable.
Fair Value Measurement, Policy [Policy Text Block]	Fair Value. The Company has adopted ASC Topic 820, “Fair Value Measurements and Disclosures” for both financial and nonfinancial assets and liabilities. The Company has not elected the fair value option for any of its assets or liabilities.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates. The accompanying financial statements are prepared in conformity with accounting principles generally accepted in the United States of America, and include certain estimates and assumptions, which affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reporting period. Accordingly, actual results may differ from those estimates.
Reclassifications [Policy Text Block]	Reclassifications. Prior period financial statement amounts have been reclassified to conform to current period presentation. The reclassifications have no effect on net loss or earnings per share.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements. Management has considered all recent accounting pronouncements in the current period and identified no pronouncements that would have an impact on our financial statements.

XML 27 R18.htm IDEA: XBRL DOCUMENT

Note 6 - Convertible Notes Payable (Tables)

9 Months Ended

Sep. 30, 2021

Notes Tables

Debt Disclosure [Table Text Block[

	September 30, 2021		December 31, 2020
Notes Payable	$	1,387,694	$	1,387,694
Accrued Interest	$	1,017,012	$	866,226
Notes Payable, related party	$	102,000	$	102,000
Accrued Interest, related Party	$	75,649	$	64,251
Total Notes Payable	$	2,582,355	$	2,420,171

XML 28 R19.htm IDEA: XBRL DOCUMENT

Note 3 - Summary of Significant Accounting Policies (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Jun. 30, 2021
Share-based Payment Arrangement, Noncash Expense, Total	$ 0	$ 0	$ 0	$ 0
Share-based Payment Arrangement, Expense	$ 0	$ 0	$ 0	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance (in shares)					0
Sale of Stock, Price Per Share (in dollars per share)	$ 0.01		$ 0.01
Preferred Stock, Capital Shares Reserved for Future Issuance (in shares)	860,000	860,000	860,000	860,000
Common Stock, Capital Shares Reserved for Future Issuance (in shares)		20,000,000.0		20,000,000.0
Series B Preferred Stock [Member]
Preferred Stock, Capital Shares Reserved for Future Issuance (in shares)	860,000	860,000	860,000	860,000
Warrents [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)			15,000,000
Preferred Shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)			6,196,893
Equity Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)			15,000,000

XML 29 R20.htm IDEA: XBRL DOCUMENT

Note 4 - Investments (Details Textual) - Preprogen LLC [Member]	1 Months Ended
	Dec. 31, 2018 USD ($)
Minority Interest Percentage	15.00%
Escrow Deposit	$ 200,583
Percentage of Royelty from Sale	5.00%
Maximum Aggregate Consideration from Royalty	$ 200,000

XML 30 R21.htm IDEA: XBRL DOCUMENT

Note 6 - Convertible Notes Payable (Details Textual) - USD ($)	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Notes Payable, Related Parties, Current	$ 177,649	$ 166,251
Directors [Member]
Notes Payable, Related Parties, Current	$ 177,649	$ 166,251
Minimum [Member]
Interest Rate	12.00%
Maximum [Member]
Interest Rate	18.00%
Date Ranges [Member]
Debt Instrument, Periodic Payment, Principal	$ 1,489,694
Bridge Notes [Member] \| Minimum [Member]
Debt Instrument, Interest Rate, Stated Percentage	12.00%
Bridge Notes [Member] \| Maximum [Member]
Debt Instrument, Interest Rate, Stated Percentage	18.00%

XML 31 R22.htm IDEA: XBRL DOCUMENT

Note 6 - Convertible Notes Payable (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Notes Payable	$ 1,387,694	$ 1,387,694
Accrued Interest	1,017,012	866,226
Notes Payable, related party	102,000	102,000
Accrued Interest, related Party	75,649	64,251
Total Notes Payable	$ 2,582,355	$ 2,420,171

XML 32 R23.htm IDEA: XBRL DOCUMENT

Note 7 - Related Party Transactions (Details Textual) - USD ($)		3 Months Ended		9 Months Ended		12 Months Ended
	Nov. 30, 2018	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020
Related Party Costs		$ 0	$ 0	$ 0	$ 10,500
Notes Payable, Related Parties, Current		177,649		177,649		$ 177,649	$ 166,251
Directors [Member]
Related Party Transaction, Expenses from Transactions with Related Party					14,085
Notes Payable, Related Parties, Current		177,649		177,649		177,649	166,251
Chief Executive Officers [Member]
Related Party Costs					3,500
Related Party Transaction, Expenses from Transactions with Related Party					$ 7,000
Directors [Member]
Related Party Transaction, Expenses from Transactions with Related Party						0
Notes Payable, Related Parties, Current		$ 177,649		$ 177,649		$ 177,649	$ 166,251
Dr. Hirschman, CEO [Member]
Payment for Management Fee	$ 3,500
Mr. Abrams [Member]
Payment for Management Fee	$ 3,500

- Definition

Direct costs arising from transactions with related parties who are not affiliates or joint Ventures. These costs are categorized as cost of goods sold.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2)
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(C))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

+ Details

XML 33 R24.htm IDEA: XBRL DOCUMENT

Note 8 - Preferred Stock (Details Textual)	9 Months Ended
Note 8 - Preferred Stock (Details Textual)	Sep. 30, 2021 USD ($) $ / shares shares	Dec. 31, 2020 $ / shares shares	Sep. 30, 2020 shares	Apr. 30, 2018 USD ($) shares	Dec. 31, 2017 USD ($)
Preferred Stock, Shares Authorized (in shares)	25,000,000	25,000,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share) \| $ / shares	$ 0.01	$ 0.01
Preferred Stock, Capital Shares Reserved for Future Issuance (in shares)	860,000		860,000
Bridge Notes Two Zero One Seven [Member]
Debt Instrument, Periodic Payment, Principal \| $	$ 86,000
Preferred Stock, Capital Shares Reserved for Future Issuance (in shares)	860,000
Debt Instrument, Unamortized Discount, Total \| $					$ 7,818
Series B Preferred Stock [Member]
Preferred Stock, Shares Authorized (in shares)	20,500,000	20,500,000
Capital Units, Value \| $	$ 204,000
Debt Instrument, Convertible, Conversion Ratio	1
Preferred Stock, Capital Shares Reserved for Future Issuance (in shares)	860,000		860,000
Preferred Stock Purchased Shares (in shares)				10,480,049
Aggregate Purchase Price \| $				$ 20,000
Preferred Stock, Shares Issued, Total (in shares)	6,196,893	6,196,893
Preferred Stock, Liquidation Preference, Value \| $	$ 61,969
Preferred Stock, Shares Outstanding, Ending Balance (in shares)	6,196,893	6,196,893

XML 34 R25.htm IDEA: XBRL DOCUMENT

Note 9 - Common Stock, Options and Warrants (Details Textual) - $ / shares	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Common Stock, Shares Authorized (in shares)	150,000,000		150,000,000
Common Stock, Shares, Issued, Total (in shares)	78,696,461		78,696,461
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)	0	0
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (in dollars per share)	$ 0.05
Common Stock, Shares, Outstanding, Ending Balance (in shares)	78,696,461		78,696,461
Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)	15,000,000.0

EXCEL 35 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 36 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 37 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 38 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 73 190 1 false 21 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://http/20210930/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Balance Sheets (Current Period Unaudited) Sheet http://http/20210930/role/statement-balance-sheets-current-period-unaudited- Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Statements of Operations (Unaudited) Sheet http://http/20210930/role/statement-statements-of-operations-unaudited Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Statements of Cash Flows (Unaudited) Sheet http://http/20210930/role/statement-statements-of-cash-flows-unaudited- Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 005 - Statement - Statements of Stockholders' Equity (Unaudited) Sheet http://http/20210930/role/statement-statements-of-stockholders-equity-unaudited Statements of Stockholders' Equity (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Description of Business and Basis of Presentation Sheet http://http/20210930/role/statement-note-1-description-of-business-and-basis-of-presentation Note 1 - Description of Business and Basis of Presentation Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Management Statement Regarding Going Concern Sheet http://http/20210930/role/statement-note-2-management-statement-regarding-going-concern Note 2 - Management Statement Regarding Going Concern Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Summary of Significant Accounting Policies Sheet http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies Note 3 - Summary of Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Investments Sheet http://http/20210930/role/statement-note-4-investments- Note 4 - Investments Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Intangible Assets Sheet http://http/20210930/role/statement-note-5-intangible-assets Note 5 - Intangible Assets Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Convertible Notes Payable Notes http://http/20210930/role/statement-note-6-convertible-notes-payable Note 6 - Convertible Notes Payable Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Related Party Transactions Sheet http://http/20210930/role/statement-note-7-related-party-transactions- Note 7 - Related Party Transactions Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Preferred Stock Sheet http://http/20210930/role/statement-note-8-preferred-stock- Note 8 - Preferred Stock Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Common Stock, Options and Warrants Sheet http://http/20210930/role/statement-note-9-common-stock-options-and-warrants Note 9 - Common Stock, Options and Warrants Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Subsequent Events Sheet http://http/20210930/role/statement-note-10-subsequent-events- Note 10 - Subsequent Events Notes 16 false false R17.htm 016 - Disclosure - Significant Accounting Policies (Policies) Sheet http://http/20210930/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies 17 false false R18.htm 017 - Disclosure - Note 6 - Convertible Notes Payable (Tables) Notes http://http/20210930/role/statement-note-6-convertible-notes-payable-tables Note 6 - Convertible Notes Payable (Tables) Tables http://http/20210930/role/statement-note-6-convertible-notes-payable 18 false false R19.htm 018 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Details Textual) Sheet http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual Note 3 - Summary of Significant Accounting Policies (Details Textual) Details 19 false false R20.htm 019 - Disclosure - Note 4 - Investments (Details Textual) Sheet http://http/20210930/role/statement-note-4-investments-details-textual Note 4 - Investments (Details Textual) Details http://http/20210930/role/statement-note-4-investments- 20 false false R21.htm 020 - Disclosure - Note 6 - Convertible Notes Payable (Details Textual) Notes http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual Note 6 - Convertible Notes Payable (Details Textual) Details http://http/20210930/role/statement-note-6-convertible-notes-payable-tables 21 false false R22.htm 021 - Disclosure - Note 6 - Convertible Notes Payable (Details) Notes http://http/20210930/role/statement-note-6-convertible-notes-payable-details Note 6 - Convertible Notes Payable (Details) Details http://http/20210930/role/statement-note-6-convertible-notes-payable-tables 22 false false R23.htm 022 - Disclosure - Note 7 - Related Party Transactions (Details Textual) Sheet http://http/20210930/role/statement-note-7-related-party-transactions-details-textual Note 7 - Related Party Transactions (Details Textual) Details http://http/20210930/role/statement-note-7-related-party-transactions- 23 false false R24.htm 023 - Disclosure - Note 8 - Preferred Stock (Details Textual) Sheet http://http/20210930/role/statement-note-8-preferred-stock-details-textual Note 8 - Preferred Stock (Details Textual) Details http://http/20210930/role/statement-note-8-preferred-stock- 24 false false R25.htm 024 - Disclosure - Note 9 - Common Stock, Options and Warrants (Details Textual) Sheet http://http/20210930/role/statement-note-9-common-stock-options-and-warrants-details-textual Note 9 - Common Stock, Options and Warrants (Details Textual) Details http://http/20210930/role/statement-note-9-common-stock-options-and-warrants 25 false false All Reports Book All Reports quan20210930_10q.htm ex_305054.htm ex_305055.htm qtxb-20210930.xsd qtxb-20210930_cal.xml qtxb-20210930_def.xml qtxb-20210930_lab.xml qtxb-20210930_pre.xml http://fasb.org/srt/2021-01-31 http://xbrl.sec.gov/dei/2021 http://fasb.org/us-gaap/2021-01-31 true true JSON 41 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "quan20210930_10q.htm": { "axisCustom": 0, "axisStandard": 9, "contextCount": 73, "dts": { "calculationLink": { "local": [ "qtxb-20210930_cal.xml" ] }, "definitionLink": { "local": [ "qtxb-20210930_def.xml" ] }, "inline": { "local": [ "quan20210930_10q.htm" ] }, "labelLink": { "local": [ "qtxb-20210930_lab.xml" ] }, "presentationLink": { "local": [ "qtxb-20210930_pre.xml" ] }, "schema": { "local": [ "qtxb-20210930.xsd" ], "remote": [ "https://xbrl.sec.gov/country/2021/country-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 190, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 43, "http://http/20210930": 1, "http://xbrl.sec.gov/dei/2021": 6, "total": 50 }, "keyCustom": 10, "keyStandard": 180, "memberCustom": 12, "memberStandard": 8, "nsprefix": "qtxb", "nsuri": "http://http/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "b", "p", "div", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://http/20210930/role/statement-document-and-entity-information", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "b", "p", "div", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Note 4 - Investments", "role": "http://http/20210930/role/statement-note-4-investments-", "shortName": "Note 4 - Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Note 5 - Intangible Assets", "role": "http://http/20210930/role/statement-note-5-intangible-assets", "shortName": "Note 5 - Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Note 6 - Convertible Notes Payable", "role": "http://http/20210930/role/statement-note-6-convertible-notes-payable", "shortName": "Note 6 - Convertible Notes Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Note 7 - Related Party Transactions", "role": "http://http/20210930/role/statement-note-7-related-party-transactions-", "shortName": "Note 7 - Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Note 8 - Preferred Stock", "role": "http://http/20210930/role/statement-note-8-preferred-stock-", "shortName": "Note 8 - Preferred Stock", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Note 9 - Common Stock, Options and Warrants", "role": "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants", "shortName": "Note 9 - Common Stock, Options and Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Note 10 - Subsequent Events", "role": "http://http/20210930/role/statement-note-10-subsequent-events-", "shortName": "Note 10 - Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Significant Accounting Policies (Policies)", "role": "http://http/20210930/role/statement-significant-accounting-policies-policies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "qtxb:DebtDisclosureTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Note 6 - Convertible Notes Payable (Tables)", "role": "http://http/20210930/role/statement-note-6-convertible-notes-payable-tables", "shortName": "Note 6 - Convertible Notes Payable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "qtxb:DebtDisclosureTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "p", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "i_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SaleOfStockPricePerShare", "reportCount": 1, "unitRef": "USDPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Details Textual)", "role": "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "shortName": "Note 3 - Summary of Significant Accounting Policies (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30_FinancialInstrumentAxis-WarrentsMember", "decimals": "INF", "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "i_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Balance Sheets (Current Period Unaudited)", "role": "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-", "shortName": "Balance Sheets (Current Period Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "i_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "p", "us-gaap:InvestmentTextBlock", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2018-12-01_2018-12-31_EquityInterestIssuedOrIssuableByTypeAxis-PreprogenLLCMember", "decimals": "2", "first": true, "lang": null, "name": "qtxb:MinorityInterestPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Note 4 - Investments (Details Textual)", "role": "http://http/20210930/role/statement-note-4-investments-details-textual", "shortName": "Note 4 - Investments (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:InvestmentTextBlock", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2018-12-01_2018-12-31_EquityInterestIssuedOrIssuableByTypeAxis-PreprogenLLCMember", "decimals": "2", "first": true, "lang": null, "name": "qtxb:MinorityInterestPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "i_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NotesPayableRelatedPartiesClassifiedCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Note 6 - Convertible Notes Payable (Details Textual)", "role": "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual", "shortName": "Note 6 - Convertible Notes Payable (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30_RangeAxis-MinimumMember", "decimals": "2", "lang": null, "name": "qtxb:InterestRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "i_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NotesPayableCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Note 6 - Convertible Notes Payable (Details)", "role": "http://http/20210930/role/statement-note-6-convertible-notes-payable-details", "shortName": "Note 6 - Convertible Notes Payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "qtxb:DebtDisclosureTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "i_2021-09-30", "decimals": "INF", "lang": null, "name": "us-gaap:OtherNotesPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-07-01_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:RelatedPartyCosts", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Note 7 - Related Party Transactions (Details Textual)", "role": "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual", "shortName": "Note 7 - Related Party Transactions (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2020-01-01_2020-09-30_RelatedPartyTransactionAxis-DirectorsMember", "decimals": "INF", "lang": null, "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "p", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "i_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Note 8 - Preferred Stock (Details Textual)", "role": "http://http/20210930/role/statement-note-8-preferred-stock-details-textual", "shortName": "Note 8 - Preferred Stock (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:PreferredStockTextBlock", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30_DebtInstrumentAxis-BridgeNotesTwoZeroOneSevenMember", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentPeriodicPaymentPrincipal", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "USDPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Note 9 - Common Stock, Options and Warrants (Details Textual)", "role": "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants-details-textual", "shortName": "Note 9 - Common Stock, Options and Warrants (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "USDPerShare", "xsiNil": "false" } }, "R3": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Balance Sheets (Current Period Unaudited) (Parentheticals)", "role": "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals", "shortName": "Balance Sheets (Current Period Unaudited) (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-07-01_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Statements of Operations (Unaudited)", "role": "http://http/20210930/role/statement-statements-of-operations-unaudited", "shortName": "Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-07-01_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-07-01_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Statements of Cash Flows (Unaudited)", "role": "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-", "shortName": "Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": "INF", "lang": null, "name": "us-gaap:IncreaseDecreaseInPrepaidExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "i_2019-12-31_FinancialInstrumentAxis-PreferredSharesMember_StatementEquityComponentsAxis-PreferredStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Statements of Stockholders' Equity (Unaudited)", "role": "http://http/20210930/role/statement-statements-of-stockholders-equity-unaudited", "shortName": "Statements of Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "i_2019-12-31_FinancialInstrumentAxis-PreferredSharesMember_StatementEquityComponentsAxis-PreferredStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "006 - Disclosure - Note 1 - Description of Business and Basis of Presentation", "role": "http://http/20210930/role/statement-note-1-description-of-business-and-basis-of-presentation", "shortName": "Note 1 - Description of Business and Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Note 2 - Management Statement Regarding Going Concern", "role": "http://http/20210930/role/statement-note-2-management-statement-regarding-going-concern", "shortName": "Note 2 - Management Statement Regarding Going Concern", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Note 3 - Summary of Significant Accounting Policies", "role": "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies", "shortName": "Note 3 - Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "quan20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 21, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-", "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals", "http://http/20210930/role/statement-document-and-entity-information", "http://http/20210930/role/statement-note-1-description-of-business-and-basis-of-presentation", "http://http/20210930/role/statement-note-10-subsequent-events-", "http://http/20210930/role/statement-note-2-management-statement-regarding-going-concern", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://http/20210930/role/statement-note-4-investments-", "http://http/20210930/role/statement-note-4-investments-details-textual", "http://http/20210930/role/statement-note-5-intangible-assets", "http://http/20210930/role/statement-note-6-convertible-notes-payable", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual", "http://http/20210930/role/statement-note-6-convertible-notes-payable-tables", "http://http/20210930/role/statement-note-7-related-party-transactions-", "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual", "http://http/20210930/role/statement-note-8-preferred-stock-", "http://http/20210930/role/statement-note-8-preferred-stock-details-textual", "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants", "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants-details-textual", "http://http/20210930/role/statement-significant-accounting-policies-policies", "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-", "http://http/20210930/role/statement-statements-of-operations-unaudited" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-", "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals", "http://http/20210930/role/statement-document-and-entity-information", "http://http/20210930/role/statement-note-1-description-of-business-and-basis-of-presentation", "http://http/20210930/role/statement-note-10-subsequent-events-", "http://http/20210930/role/statement-note-2-management-statement-regarding-going-concern", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://http/20210930/role/statement-note-4-investments-", "http://http/20210930/role/statement-note-4-investments-details-textual", "http://http/20210930/role/statement-note-5-intangible-assets", "http://http/20210930/role/statement-note-6-convertible-notes-payable", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual", "http://http/20210930/role/statement-note-6-convertible-notes-payable-tables", "http://http/20210930/role/statement-note-7-related-party-transactions-", "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual", "http://http/20210930/role/statement-note-8-preferred-stock-", "http://http/20210930/role/statement-note-8-preferred-stock-details-textual", "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants", "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants-details-textual", "http://http/20210930/role/statement-significant-accounting-policies-policies", "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-", "http://http/20210930/role/statement-statements-of-operations-unaudited" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://http/20210930/role/statement-document-and-entity-information" ], "xbrltype": "securityTitleItemType" }, "qtxb_AggregatePurchasePrice": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents aggregate purchase price.", "label": "qtxb_AggregatePurchasePrice", "terseLabel": "Aggregate Purchase Price" } } }, "localname": "AggregatePurchasePrice", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "monetaryItemType" }, "qtxb_BridgeNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the Company's Bridge Notes information.", "label": "Bridge Notes [Member]" } } }, "localname": "BridgeNotesMember", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual" ], "xbrltype": "domainItemType" }, "qtxb_BridgeNotesTwoZeroOneSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents bridge notes two zero one seven.", "label": "Bridge Notes Two Zero One Seven [Member]" } } }, "localname": "BridgeNotesTwoZeroOneSevenMember", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-8-preferred-stock-", "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "domainItemType" }, "qtxb_ChiefExecutiveOfficersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents chief executive officers.", "label": "Chief Executive Officers [Member]" } } }, "localname": "ChiefExecutiveOfficersMember", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-7-related-party-transactions-", "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual" ], "xbrltype": "domainItemType" }, "qtxb_DateRangesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents date ranges.", "label": "Date Ranges [Member]" } } }, "localname": "DateRangesMember", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual" ], "xbrltype": "domainItemType" }, "qtxb_DebtDisclosureTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents debt disclosure table text block.", "label": "Debt Disclosure [Table Text Block[" } } }, "localname": "DebtDisclosureTableTextBlock", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable-tables" ], "xbrltype": "textBlockItemType" }, "qtxb_DirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents directors.", "label": "Directors [Member]" } } }, "localname": "DirectorsMember", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual", "http://http/20210930/role/statement-note-7-related-party-transactions-", "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual" ], "xbrltype": "domainItemType" }, "qtxb_DrHirschmanCeoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents CEO, Dr. Hirschman.", "label": "Dr. Hirschman, CEO [Member]" } } }, "localname": "DrHirschmanCeoMember", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-7-related-party-transactions-", "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual" ], "xbrltype": "domainItemType" }, "qtxb_InterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents interest rate.", "label": "qtxb_InterestRate", "terseLabel": "Interest Rate" } } }, "localname": "InterestRate", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual" ], "xbrltype": "percentItemType" }, "qtxb_MaximumAggregateConsiderationFromRoyalty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents maximum aggregate consideration from Royalty.", "label": "qtxb_MaximumAggregateConsiderationFromRoyalty", "terseLabel": "Maximum Aggregate Consideration from Royalty" } } }, "localname": "MaximumAggregateConsiderationFromRoyalty", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-4-investments-details-textual" ], "xbrltype": "monetaryItemType" }, "qtxb_MinorityInterestPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents minority interest percentage.", "label": "qtxb_MinorityInterestPercentage", "terseLabel": "Minority Interest Percentage" } } }, "localname": "MinorityInterestPercentage", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-4-investments-details-textual" ], "xbrltype": "percentItemType" }, "qtxb_MrAbramsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents director, Mr. Abrams.", "label": "Mr. Abrams [Member]" } } }, "localname": "MrAbramsMember", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-7-related-party-transactions-", "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual" ], "xbrltype": "domainItemType" }, "qtxb_NoteToFinancialStatementDetailsTextual": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note To Financial Statement Details Textual" } } }, "localname": "NoteToFinancialStatementDetailsTextual", "nsuri": "http://http/20210930", "xbrltype": "stringItemType" }, "qtxb_NotesToFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes To Financial Statements [Abstract]" } } }, "localname": "NotesToFinancialStatementsAbstract", "nsuri": "http://http/20210930", "xbrltype": "stringItemType" }, "qtxb_OtherInterestPayableCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents other interest payable current.", "label": "Accrued Interest, related Party" } } }, "localname": "OtherInterestPayableCurrent", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable-details" ], "xbrltype": "monetaryItemType" }, "qtxb_PercentageOfRoyeltyFromSale": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of Royelty from sale.", "label": "qtxb_PercentageOfRoyeltyFromSale", "terseLabel": "Percentage of Royelty from Sale" } } }, "localname": "PercentageOfRoyeltyFromSale", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-4-investments-details-textual" ], "xbrltype": "percentItemType" }, "qtxb_PreferredSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents preferred shares.", "label": "Preferred Shares [Member]" } } }, "localname": "PreferredSharesMember", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://http/20210930/role/statement-statements-of-stockholders-equity-unaudited" ], "xbrltype": "domainItemType" }, "qtxb_PreferredStockPurchasedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Preferred stock purchased shares.", "label": "qtxb_PreferredStockPurchasedShares", "terseLabel": "Preferred Stock Purchased Shares (in shares)" } } }, "localname": "PreferredStockPurchasedShares", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "sharesItemType" }, "qtxb_PreprogenLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Preprogen LLC.", "label": "Preprogen LLC [Member]" } } }, "localname": "PreprogenLLCMember", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-4-investments-", "http://http/20210930/role/statement-note-4-investments-details-textual" ], "xbrltype": "domainItemType" }, "qtxb_ReclassificationsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents reclassifications.", "label": "Reclassifications [Policy Text Block]" } } }, "localname": "ReclassificationsPolicyTextBlock", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "qtxb_StockToBeIssued": { "auth_ref": [], "calculation": { "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents amount of stock to be issued.", "label": "Stock to be issued" } } }, "localname": "StockToBeIssued", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-" ], "xbrltype": "monetaryItemType" }, "qtxb_StockToBeIssuedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents stock to be issued.", "label": "Stock to be Issued [Member]" } } }, "localname": "StockToBeIssuedMember", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-statements-of-stockholders-equity-unaudited" ], "xbrltype": "domainItemType" }, "qtxb_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents warrants.", "label": "Warrants [Member]" } } }, "localname": "WarrantsMember", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants", "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants-details-textual" ], "xbrltype": "domainItemType" }, "qtxb_WarrentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents warrents.", "label": "Warrents [Member]" } } }, "localname": "WarrentsMember", "nsuri": "http://http/20210930", "presentation": [ "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual" ], "xbrltype": "domainItemType" }, "qtxb_statement-statement-note-6-convertible-notes-payable-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 6 - Convertible Notes Payable (Details)" } } }, "localname": "statement-statement-note-6-convertible-notes-payable-details", "nsuri": "http://http/20210930", "xbrltype": "stringItemType" }, "qtxb_statement-statement-note-6-convertible-notes-payable-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 6 - Convertible Notes Payable" } } }, "localname": "statement-statement-note-6-convertible-notes-payable-tables", "nsuri": "http://http/20210930", "xbrltype": "stringItemType" }, "qtxb_statement-statement-significant-accounting-policies-policies": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies" } } }, "localname": "statement-statement-significant-accounting-policies-policies", "nsuri": "http://http/20210930", "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r154", "r188", "r209", "r210", "r265", "r266", "r267", "r268", "r269", "r270", "r289", "r322", "r323", "r333", "r334" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r154", "r188", "r209", "r210", "r265", "r266", "r267", "r268", "r269", "r270", "r289", "r322", "r323", "r333", "r334" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r154", "r188", "r207", "r209", "r210", "r265", "r266", "r267", "r268", "r269", "r270", "r289", "r322", "r323", "r333", "r334" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r154", "r188", "r207", "r209", "r210", "r265", "r266", "r267", "r268", "r269", "r270", "r289", "r322", "r323", "r333", "r334" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-significant-accounting-policies-policies" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r23", "r256" ], "calculation": { "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-": { "order": 0.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r15", "r220", "r256" ], "calculation": { "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r67", "r68", "r69", "r217", "r218", "r219", "r231" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-stockholders-equity-unaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r211", "r215", "r221" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "us-gaap_AllocatedShareBasedCompensationExpense", "terseLabel": "Share-based Payment Arrangement, Expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r63", "r104", "r107", "r111", "r123", "r138", "r139", "r140", "r142", "r143", "r144", "r145", "r146", "r147", "r149", "r150", "r226", "r228", "r233", "r254", "r256", "r304", "r315" ], "calculation": { "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "us-gaap_Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r6", "r34", "r63", "r123", "r138", "r139", "r140", "r142", "r143", "r144", "r145", "r146", "r147", "r149", "r150", "r226", "r228", "r233", "r254", "r256" ], "calculation": { "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-": { "order": 0.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "us-gaap_AssetsCurrent", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r3", "r66", "r102" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-1-description-of-business-and-basis-of-presentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalUnits": { "auth_ref": [ "r329" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of capital units or capital shares. This element is relevant to issuers of face-amount certificates and registered investment companies.", "label": "us-gaap_CapitalUnits", "terseLabel": "Capital Units, Value" } } }, "localname": "CapitalUnits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r4", "r20", "r55" ], "calculation": { "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-": { "order": 0.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r49", "r55", "r57" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "periodEndLabel": "Cash and Cash Equivalents, End of Period", "periodStartLabel": "Cash and Cash Equivalents, Beginning of Period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r49", "r234" ], "calculation": { "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "totalLabel": "Net Increase (Decrease) in Cash and Cash Equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r60", "r63", "r79", "r80", "r81", "r83", "r87", "r92", "r93", "r94", "r123", "r138", "r143", "r144", "r145", "r149", "r150", "r186", "r187", "r190", "r194", "r233", "r339" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://http/20210930/role/statement-note-8-preferred-stock-", "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r30", "r137", "r309", "r319" ], "calculation": { "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "terseLabel": "Common Stock, Capital Shares Reserved for Future Issuance (in shares)" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r67", "r68", "r231" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-stockholders-equity-unaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, authorized (in shares)", "terseLabel": "Common Stock, Shares Authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals", "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, issued (in shares)", "terseLabel": "Common Stock, Shares, Issued, Total (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals", "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r14", "r201" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, outstanding (in shares)", "terseLabel": "Common Stock, Shares, Outstanding, Ending Balance (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals", "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r14", "r256" ], "calculation": { "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock; $0.01 par value; 150,000,000 authorized; 78,696,461 shares issued and outstanding" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r43" ], "calculation": { "http://http/20210930/role/statement-statements-of-operations-unaudited": { "order": 0.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "us-gaap_CostsAndExpenses", "totalLabel": "Total Costs and Operating Expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Operating Expense:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-operations-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r59", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r168", "r175", "r176", "r178", "r185" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r9", "r10", "r11", "r62", "r65", "r151", "r152", "r153", "r154", "r155", "r156", "r158", "r164", "r165", "r166", "r167", "r169", "r170", "r171", "r172", "r173", "r174", "r179", "r180", "r181", "r182", "r244", "r305", "r306", "r314" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual", "http://http/20210930/role/statement-note-8-preferred-stock-", "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleConversionRatio1": { "auth_ref": [ "r28", "r153", "r202", "r203", "r204" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.", "label": "us-gaap_DebtInstrumentConvertibleConversionRatio1", "terseLabel": "Debt Instrument, Convertible, Conversion Ratio" } } }, "localname": "DebtInstrumentConvertibleConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "pureItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r27", "r152" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "us-gaap_DebtInstrumentInterestRateStatedPercentage", "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r29", "r62", "r65", "r151", "r152", "r153", "r154", "r155", "r156", "r158", "r164", "r165", "r166", "r167", "r169", "r170", "r171", "r172", "r173", "r174", "r179", "r180", "r181", "r182", "r244" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual", "http://http/20210930/role/statement-note-8-preferred-stock-", "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": { "auth_ref": [ "r29" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments applied to principal.", "label": "us-gaap_DebtInstrumentPeriodicPaymentPrincipal", "terseLabel": "Debt Instrument, Periodic Payment, Principal" } } }, "localname": "DebtInstrumentPeriodicPaymentPrincipal", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual", "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r164", "r242", "r245" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "us-gaap_DebtInstrumentUnamortizedDiscount", "terseLabel": "Debt Instrument, Unamortized Discount, Total" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "us-gaap_DisclosureTextBlockAbstract", "terseLabel": "Notes to Financial Statements" } } }, "localname": "DisclosureTextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-1-description-of-business-and-basis-of-presentation", "http://http/20210930/role/statement-note-10-subsequent-events-", "http://http/20210930/role/statement-note-2-management-statement-regarding-going-concern", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies", "http://http/20210930/role/statement-note-4-investments-", "http://http/20210930/role/statement-note-5-intangible-assets", "http://http/20210930/role/statement-note-6-convertible-notes-payable", "http://http/20210930/role/statement-note-7-related-party-transactions-", "http://http/20210930/role/statement-note-8-preferred-stock-", "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Basic and Diluted Net Loss per Common Share (in dollars per share)" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-operations-unaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r88", "r89" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r37", "r38", "r39", "r67", "r68", "r69", "r71", "r76", "r78", "r91", "r126", "r201", "r205", "r217", "r218", "r219", "r222", "r223", "r231", "r235", "r236", "r237", "r238", "r239", "r240", "r324", "r325", "r326", "r347" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-stockholders-equity-unaudited" ], "xbrltype": "domainItemType" }, "us-gaap_EquityInterestIssuedOrIssuableByTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of equity interests that are issued or issuable in a business combination.", "label": "Equity Interest Type [Axis]" } } }, "localname": "EquityInterestIssuedOrIssuableByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-4-investments-", "http://http/20210930/role/statement-note-4-investments-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_EquityInterestIssuedOrIssuableTypeDomain": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Name of equity interest issued or issuable to acquire an entity in a business combination.", "label": "Equity Interest Issued or Issuable, Type [Domain]" } } }, "localname": "EquityInterestIssuedOrIssuableTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-4-investments-", "http://http/20210930/role/statement-note-4-investments-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": { "auth_ref": [ "r121" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.", "label": "Investments, impairment" } } }, "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r21", "r105", "r122" ], "calculation": { "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Investments, net of impairment of $500,000" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_EscrowDeposit": { "auth_ref": [ "r308", "r332" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.", "label": "us-gaap_EscrowDeposit", "terseLabel": "Escrow Deposit" } } }, "localname": "EscrowDeposit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-4-investments-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r114", "r115", "r117", "r118", "r119", "r127", "r128", "r129", "r130", "r131", "r132", "r133", "r134", "r135", "r177", "r199", "r230", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r339", "r340", "r341", "r342", "r343", "r344", "r345" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants", "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants-details-textual", "http://http/20210930/role/statement-statements-of-stockholders-equity-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r53", "r183", "r184" ], "calculation": { "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://http/20210930/role/statement-statements-of-operations-unaudited": { "order": 0.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (loss) on forgiveness of accounts payable", "negatedLabel": "Loss (gain) on forgiveness of accounts payable" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-", "http://http/20210930/role/statement-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncentiveDistributionMadeToManagingMemberOrGeneralPartnerAxis": { "auth_ref": [ "r85", "r86", "r90", "r205" ], "lang": { "en-us": { "role": { "documentation": "Information by managing member or partner type.", "label": "Managing Member or General Partner [Axis]" } } }, "localname": "IncentiveDistributionMadeToManagingMemberOrGeneralPartnerAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-7-related-party-transactions-", "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_IncentiveDistributionRecipientDomain": { "auth_ref": [ "r85", "r90" ], "lang": { "en-us": { "role": { "documentation": "The managing member or general partner receiving the distribution.", "label": "Incentive Distribution, Recipient [Domain]" } } }, "localname": "IncentiveDistributionRecipientDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-7-related-party-transactions-", "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r41", "r104", "r106", "r109", "r110", "r112", "r303", "r310", "r313", "r321" ], "calculation": { "http://http/20210930/role/statement-statements-of-operations-unaudited": { "order": 0.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "totalLabel": "Profit (Loss) Before Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r63", "r70", "r104", "r106", "r109", "r110", "r112", "r123", "r138", "r139", "r140", "r143", "r144", "r145", "r146", "r147", "r149", "r150", "r225", "r232", "r233" ], "calculation": { "http://http/20210930/role/statement-statements-of-operations-unaudited": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.", "label": "Provision for Income Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r56" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income tax paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "auth_ref": [ "r52" ], "calculation": { "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.", "label": "Accrued interest" } } }, "localname": "IncreaseDecreaseInInterestPayableNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "(Increase) Decrease in:" } } }, "localname": "IncreaseDecreaseInOperatingAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in:" } } }, "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayable": { "auth_ref": [ "r52" ], "calculation": { "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Accounts Payable" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r52" ], "calculation": { "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "us-gaap_IncreaseDecreaseInPrepaidExpense", "negatedLabel": "Prepaid expense" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-5-intangible-assets" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r40", "r103", "r241", "r243", "r312" ], "calculation": { "http://http/20210930/role/statement-statements-of-operations-unaudited": { "order": 1.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "us-gaap_InterestExpense", "negatedLabel": "Interest Expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r47", "r50", "r56" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest expense paid in cash" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r7", "r8", "r26" ], "calculation": { "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued interest on notes payable", "terseLabel": "Accrued Interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTextBlock": { "auth_ref": [ "r116", "r120", "r124", "r125" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investment.", "label": "Investment [Text Block]" } } }, "localname": "InvestmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-4-investments-" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r25", "r63", "r108", "r123", "r138", "r139", "r140", "r143", "r144", "r145", "r146", "r147", "r149", "r150", "r227", "r228", "r229", "r233", "r254", "r255" ], "calculation": { "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "us-gaap_Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r19", "r63", "r123", "r233", "r256", "r307", "r318" ], "calculation": { "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "us-gaap_LiabilitiesAndStockholdersEquity", "totalLabel": "Total Liabilities and Stockholders\u2019 Equity (Deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r49" ], "calculation": { "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided (Used) by Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r49" ], "calculation": { "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r49", "r51", "r54" ], "calculation": { "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-": { "order": 0.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "totalLabel": "Net Cash Used by Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r35", "r36", "r39", "r42", "r54", "r63", "r70", "r72", "r73", "r74", "r75", "r77", "r78", "r82", "r104", "r106", "r109", "r110", "r112", "r123", "r138", "r139", "r140", "r143", "r144", "r145", "r146", "r147", "r149", "r150", "r232", "r233", "r311", "r320" ], "calculation": { "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://http/20210930/role/statement-statements-of-operations-unaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "Net Profit (Loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-", "http://http/20210930/role/statement-statements-of-operations-unaudited", "http://http/20210930/role/statement-statements-of-stockholders-equity-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income (Expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-operations-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r11", "r306", "r316" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Total Notes Payable" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes Payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r22", "r64", "r250" ], "calculation": { "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes Payable, related party and accrued interest", "terseLabel": "Notes Payable, Related Parties, Current" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual", "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r104", "r106", "r109", "r110", "r112" ], "calculation": { "http://http/20210930/role/statement-statements-of-operations-unaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "us-gaap_OperatingIncomeLoss", "totalLabel": "LOSS FROM OPERATIONS:" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r46" ], "calculation": { "http://http/20210930/role/statement-statements-of-operations-unaudited": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "us-gaap_OtherNonoperatingIncomeExpense", "totalLabel": "Total Other Income (Expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNotesPayableCurrent": { "auth_ref": [ "r26" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Notes Payable, related party" } } }, "localname": "OtherNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentForManagementFee": { "auth_ref": [ "r48", "r248" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount paid to managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).", "label": "us-gaap_PaymentForManagementFee", "terseLabel": "Payment for Management Fee" } } }, "localname": "PaymentForManagementFee", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_PolicyTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "us-gaap_PolicyTextBlockAbstract", "terseLabel": "Accounting Policies" } } }, "localname": "PolicyTextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-significant-accounting-policies-policies" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r31" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of nonredeemable preferred shares reserved for future issuance.", "label": "us-gaap_PreferredStockCapitalSharesReservedForFutureIssuance", "terseLabel": "Preferred Stock, Capital Shares Reserved for Future Issuance (in shares)" } } }, "localname": "PreferredStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockLiquidationPreferenceValue": { "auth_ref": [ "r60", "r190" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.", "label": "us-gaap_PreferredStockLiquidationPreferenceValue", "terseLabel": "Preferred Stock, Liquidation Preference, Value" } } }, "localname": "PreferredStockLiquidationPreferenceValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-stockholders-equity-unaudited" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r13", "r186" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value (in dollars per share)", "terseLabel": "Preferred Stock, Par or Stated Value Per Share (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals", "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized (in shares)", "terseLabel": "Preferred Stock, Shares Authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals", "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r13", "r186" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, Issued (in shares)", "terseLabel": "Preferred Stock, Shares Issued, Total (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals", "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, Outstanding (in shares)", "terseLabel": "Preferred Stock, Shares Outstanding, Ending Balance (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals", "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockTextBlock": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.", "label": "Preferred Stock [Text Block]" } } }, "localname": "PreferredStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-8-preferred-stock-" ], "xbrltype": "textBlockItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r13", "r256" ], "calculation": { "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock; $0.01 par value, 25,000,000 authorized shares; 20,500,000 shares designated as Series B Convertible Preferred Stock; Series B Convertible Preferred shares 6,196,893 issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r330", "r331" ], "calculation": { "http://http/20210930/role/statement-statements-of-operations-unaudited": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyCosts": { "auth_ref": [ "r44", "r64", "r141", "r143", "r144", "r148", "r149", "r150" ], "calculation": { "http://http/20210930/role/statement-statements-of-operations-unaudited": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Direct costs arising from transactions with related parties who are not affiliates or joint Ventures. These costs are categorized as cost of goods sold.", "label": "Professional fees, related party", "terseLabel": "Related Party Costs" } } }, "localname": "RelatedPartyCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual", "http://http/20210930/role/statement-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r208", "r248", "r249" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-7-related-party-transactions-", "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r208", "r248", "r249", "r251" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual", "http://http/20210930/role/statement-note-7-related-party-transactions-", "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual", "http://http/20210930/role/statement-note-7-related-party-transactions-", "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r248" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "terseLabel": "Related Party Transaction, Expenses from Transactions with Related Party" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r208", "r248", "r251", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-7-related-party-transactions-", "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r246", "r247", "r249", "r252", "r253" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-7-related-party-transactions-" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r16", "r205", "r220", "r256", "r317", "r327", "r328" ], "calculation": { "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r67", "r68", "r69", "r71", "r76", "r78", "r126", "r217", "r218", "r219", "r222", "r223", "r231", "r324", "r326" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-stockholders-equity-unaudited" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "us-gaap_SaleOfStockPricePerShare", "terseLabel": "Sale of Stock, Price Per Share (in dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual" ], "xbrltype": "perShareItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r45" ], "calculation": { "http://http/20210930/role/statement-statements-of-operations-unaudited": { "order": 0.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Sales, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://http/20210930/role/statement-note-8-preferred-stock-", "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r52" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "us-gaap_ShareBasedCompensation", "terseLabel": "Share-based Payment Arrangement, Noncash Expense, Total" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r214", "r216" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "terseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants-details-textual" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r212", "r213" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Payment Arrangement [Policy Text Block]" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "us-gaap_SharesOutstanding", "periodEndLabel": "BALANCE (in shares)", "periodStartLabel": "BALANCE (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-stockholders-equity-unaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r58", "r66" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r12", "r13", "r14", "r60", "r63", "r79", "r80", "r81", "r83", "r87", "r92", "r93", "r94", "r123", "r138", "r143", "r144", "r145", "r149", "r150", "r186", "r187", "r190", "r194", "r201", "r233", "r339" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://http/20210930/role/statement-note-8-preferred-stock-", "http://http/20210930/role/statement-note-8-preferred-stock-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r33", "r37", "r38", "r39", "r67", "r68", "r69", "r71", "r76", "r78", "r91", "r126", "r201", "r205", "r217", "r218", "r219", "r222", "r223", "r231", "r235", "r236", "r237", "r238", "r239", "r240", "r324", "r325", "r326", "r347" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-stockholders-equity-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-", "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals", "http://http/20210930/role/statement-note-1-description-of-business-and-basis-of-presentation", "http://http/20210930/role/statement-note-10-subsequent-events-", "http://http/20210930/role/statement-note-2-management-statement-regarding-going-concern", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://http/20210930/role/statement-note-4-investments-", "http://http/20210930/role/statement-note-4-investments-details-textual", "http://http/20210930/role/statement-note-5-intangible-assets", "http://http/20210930/role/statement-note-6-convertible-notes-payable", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual", "http://http/20210930/role/statement-note-6-convertible-notes-payable-tables", "http://http/20210930/role/statement-note-7-related-party-transactions-", "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual", "http://http/20210930/role/statement-note-8-preferred-stock-", "http://http/20210930/role/statement-note-8-preferred-stock-details-textual", "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants", "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants-details-textual", "http://http/20210930/role/statement-significant-accounting-policies-policies", "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-", "http://http/20210930/role/statement-statements-of-operations-unaudited", "http://http/20210930/role/statement-statements-of-stockholders-equity-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r67", "r68", "r69", "r91", "r290" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-", "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-parentheticals", "http://http/20210930/role/statement-note-1-description-of-business-and-basis-of-presentation", "http://http/20210930/role/statement-note-10-subsequent-events-", "http://http/20210930/role/statement-note-2-management-statement-regarding-going-concern", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://http/20210930/role/statement-note-4-investments-", "http://http/20210930/role/statement-note-4-investments-details-textual", "http://http/20210930/role/statement-note-5-intangible-assets", "http://http/20210930/role/statement-note-6-convertible-notes-payable", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details", "http://http/20210930/role/statement-note-6-convertible-notes-payable-details-textual", "http://http/20210930/role/statement-note-6-convertible-notes-payable-tables", "http://http/20210930/role/statement-note-7-related-party-transactions-", "http://http/20210930/role/statement-note-7-related-party-transactions-details-textual", "http://http/20210930/role/statement-note-8-preferred-stock-", "http://http/20210930/role/statement-note-8-preferred-stock-details-textual", "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants", "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants-details-textual", "http://http/20210930/role/statement-significant-accounting-policies-policies", "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-", "http://http/20210930/role/statement-statements-of-operations-unaudited", "http://http/20210930/role/statement-statements-of-stockholders-equity-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r14", "r17", "r18", "r63", "r113", "r123", "r233", "r256" ], "calculation": { "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "us-gaap_StockholdersEquity", "periodEndLabel": "BALANCE", "periodStartLabel": "BALANCE", "totalLabel": "Total Stockholders\u2019 Equity (Deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-", "http://http/20210930/role/statement-statements-of-stockholders-equity-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Deficit):" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-balance-sheets-current-period-unaudited-" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r61", "r187", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r200", "r205", "r206" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r257", "r258" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-10-subsequent-events-" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Substantial Doubt about Going Concern [Text Block]" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-2-management-statement-regarding-going-concern" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Disclosures:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-cash-flows-unaudited-" ], "xbrltype": "stringItemType" }, "us-gaap_TableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "us-gaap_TableTextBlock", "terseLabel": "Notes Tables" } } }, "localname": "TableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-6-convertible-notes-payable-tables" ], "xbrltype": "stringItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r114", "r115", "r117", "r118", "r119", "r177", "r199", "r230", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r339", "r340", "r341", "r342", "r343", "r344", "r345" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies", "http://http/20210930/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants", "http://http/20210930/role/statement-note-9-common-stock-options-and-warrants-details-textual", "http://http/20210930/role/statement-statements-of-stockholders-equity-unaudited" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r95", "r96", "r97", "r98", "r99", "r100", "r101" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Basic and Diluted Weighted Average Shares Used in per Share Calculation (in shares)" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://http/20210930/role/statement-statements-of-operations-unaudited" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r102": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563" }, "r116": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "321", "URI": "http://asc.fasb.org/topic&trid=75115024" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=124268079&loc=d3e32787-111569" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r124": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "http://asc.fasb.org/topic&trid=2196965" }, "r125": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "325", "URI": "http://asc.fasb.org/topic&trid=2197064" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r136": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629" }, "r185": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=51888271" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r206": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r253": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r258": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.16(a))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(d)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r335": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r336": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r337": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r338": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r339": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r341": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r342": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r343": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r344": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r345": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r346": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r66": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "72", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6926462&loc=SL5163672-159010" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "73", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6926462&loc=SL5163674-159010" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "103", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243028&loc=SL5199526-159011" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" } }, "version": "2.1" } ZIP 42 0001851734-21-000104-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001851734-21-000104-xbrl.zip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˹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�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end